Regulation of Dpp target genes by Mad/Medea and Brinker by Weiss, Alexander
 
 
 
 
Regulation of Dpp target genes by 
Mad/Medea and Brinker 
 
 
 
 
 
 
Inauguraldissertation 
 
 
 
 
 
zur 
Erlangung der Würde eines Doktors der Philosophie 
vorgelegt der 
Philosophisch-Naturwissenschaftlichen Fakultät 
der Universität Basel 
 
von 
 
 
 
Alexander Weiss 
aus 
Freiburg im Breisgau 
Deutschland 
 
 
in Basel 
im März 2009  
 
 
 
 
Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät 
auf Antrag von 
 
 
Prof. Dr. Markus Affolter  Prof. Dr. Rolf Zeller 
(Dissertationsleiter)   (Koreferent)  
 
 
Basel, 16. September 2008 
 
 
 Prof. Dr. Eberhard Parlow 
 (Dekan der Philosophisch- 
 Naturwissenschaftlichen Fakultät) 
 
 
 
 
 
 
 
 
 
 
Die vorliegende Arbeit wurde angefertigt unter der Leitung von 
 
Prof. Dr. Markus Affolter 
 
im Zeitraum vom Juli 2004 bis September 2008 
in der Abteilung Zellbiologie des Biozentrums der Universität Basel 
 
 
 
 
Hiermit erkläre ich, dass ich die Arbeit eigenständig verfasst und an keiner weiteren 
Fakultät eingereicht, sowie keine anderen als die angegebenen Quellen und Hilfsmittel 
hinzugezogen habe. 
 
 
Basel, im September 2008 
 
Alexander Weiss 
Table of Contents 
 
 
 
4
1 Table of Contents 
1 TABLE OF CONTENTS ................................................................................................... 4 
2 LIST OF ABBREVIATIONS............................................................................................ 6 
3 ABSTRACT ........................................................................................................................ 9 
4 INTRODUCTION ............................................................................................................ 10 
4.1 THE TGF-β SUPERFAMILY .......................................................................................... 10 
4.2 THE TGF-β SIGNALLING PATHWAY ............................................................................ 11 
4.3 DPP SIGNALLING IN DROSOPHILA ................................................................................ 14 
4.3.1 Dpp acts as a morphogen ................................................................................ 14 
4.3.2 The role of Brinker .......................................................................................... 16 
4.3.3 Regulation of Brinker ...................................................................................... 17 
4.3.4 The role of Schnurri......................................................................................... 19 
4.4 AIM OF THE STUDY...................................................................................................... 20 
4.4.1 Search for an SE counterpart .......................................................................... 20 
4.4.2 Transcriptional regulation of inhibitory Smads .............................................. 21 
4.4.3 Strategy............................................................................................................ 22 
5 MATERIAL AND METHODS ....................................................................................... 23 
5.1 GENERATION OF TRANSGENIC FLIES............................................................................ 23 
5.1.1 Cloning of reporter constructs ........................................................................ 23 
5.1.2 Cloning of BrkVP16......................................................................................... 25 
5.1.3 P-element mediated transfomation.................................................................. 25 
5.1.4 Transformation using the attB/attP system ..................................................... 26 
5.2 S2 REPORTER ASSAY ................................................................................................... 26 
5.2.1 Maintenance and transfection of S2 cells........................................................ 26 
5.2.2 Preparation and analysis of cell extracts ........................................................ 26 
5.2.3 Solutions .......................................................................................................... 26 
5.3 ELECTROPHORETIC MOBILITY SHIFT ASSAY ................................................................ 27 
5.3.1 Bacterially produced proteins ......................................................................... 27 
5.3.2 Production of cell extracts............................................................................... 27 
5.3.3 Preparation of radioactively labeled probe .................................................... 27 
5.3.4 Electrophoretic mobility shift assay ................................................................ 28 
5.3.5 Solutions .......................................................................................................... 28 
5.4 CO-PRECIPITATION OF PSMAD..................................................................................... 29 
5.4.1 Procedure ........................................................................................................ 29 
5.4.2 Solutions .......................................................................................................... 29 
5.5 EXPRESSION ANALYSIS IN FLY AND FISH ..................................................................... 30 
5.5.1 Collection and fixation of Drosophila embryos .............................................. 30 
5.5.2 Whole mount Drosophila embryo in situ hybridization................................... 30 
5.5.3 Whole mount Drosophila embryo antibody staining....................................... 31 
5.5.4 XGal staining imaginal discs........................................................................... 32 
5.5.5 XGal staining zebrafish embryos..................................................................... 32 
5.5.6 Documentation ................................................................................................ 33 
5.6 BIOINFORMATIC TOOLS............................................................................................... 33 
5.7 FLY STRAINS ............................................................................................................... 34 
6 RESULTS.......................................................................................................................... 35 
6.1 ANALYSIS OF DAD EXPRESSION AND REGULATION ...................................................... 35 
Table of Contents 
 
 
 
5
6.1.1 dad expression follows dpp expression ........................................................... 35 
6.1.2 dad expression is regulated by the Dpp pathway and Brinker........................ 36 
6.2 IDENTIFICATION OF A MINIMAL DAD ENHANCER.......................................................... 37 
6.2.1 A lacZ reporter driven by the second dad intron resembles endogenous dad 
expression................................................................................................................... 37 
6.2.2 The minimal enhancer Dad13 contains putative Smad and Brinker binding 
sites and is highly conserved...................................................................................... 38 
6.2.3 Trimming of Dad13 leads to loss of activity.................................................... 40 
6.2.4 The minimal enhancer is regulated by Dpp and Brinker in vivo and in cell 
culture 41 
6.3 DISSECTION OF THE MINIMAL ENHANCER BY BIOCHEMICAL ANALYSES ...................... 44 
6.3.1 Mad/Medea and Brinker DNA binding domains bind to the dad enhancer.... 44 
6.3.2 Mad/Medea and Brinker compete for binding sites ........................................ 47 
6.3.3 Binding of Mad/Medea and Brinker to Ubx and zen enhancer....................... 48 
6.3.4 Converting Mad/Brinker sites into exclusive Mad sites .................................. 49 
6.3.5 A complex of full length Mad/Medea proteins is recruited onto the enhancer51 
6.3.6 Identification of the minimal element that is able to recruit Mad/Medea....... 53 
6.3.7 The minimal Mad/Medea binding element resembles the SE.......................... 55 
6.3.8 Definition of the AE consensus sequence ........................................................ 55 
6.3.9 Testing of the spalt and Ubx enhancers for Mad/Medea complex formation . 56 
6.3.10 Confirmation of the transcription factor binding sites in vivo ........................ 57 
6.3.11 Functional dissection of the AE in vivo ........................................................... 60 
6.3.12 Search for co-activators acting on the AE....................................................... 63 
6.4 IDENTIFICATION OF NOVEL DPP ACTIVATED ENHANCERS............................................ 64 
6.4.1 In silico screen for AEs.................................................................................... 64 
6.4.2 Crossveinless-2................................................................................................ 65 
6.4.3 Elbow B............................................................................................................ 67 
6.4.4 Dorsocross....................................................................................................... 68 
6.4.5 Knirps .............................................................................................................. 71 
6.4.6 Pannier ............................................................................................................ 73 
6.4.7 Another dad enhancer ..................................................................................... 75 
6.5 THE FUNCTION OF THE AE IS PYLOGENETICALLY CONSERVED.................................... 76 
7 DISCUSSION.................................................................................................................... 78 
7.1 THE GENETIC BASIS OF EVOLUTION............................................................................. 78 
7.2 REGULATION OF THE DPP-ANTAGONIST DAD.............................................................. 79 
7.2.1 Function of Dad............................................................................................... 79 
7.2.2 Genetic control of dad expression ................................................................... 80 
7.2.3 Regulation of a minimal dad enhancer ........................................................... 81 
7.2.4 The AE as an integrative activating Dpp response element............................ 82 
7.2.5 Flexibility and adaptability of the AE.............................................................. 84 
7.2.6 Discovery of a Dpp synregulation group ........................................................ 85 
7.2.7 Phylogenetic conservation of the AE............................................................... 86 
7.2.8 Open questions ................................................................................................ 87 
8 ACKNOWLEDGEMENTS ............................................................................................. 88 
9 REFERENCES ................................................................................................................. 89 
 
List of Abbreviations 
 
 
 
6
2 List of Abbreviations 
 
α Anti 
aa amino acid 
AE Activating Element 
ALK Activin receptor-like kinase 
AP Alkaline phosphatase 
Ap Apterous 
AP-1 Activator protein 1 
APS Ammonium persulfate 
ATET ABC transporter expressed in trachea 
ATP Adenosine triphosphate 
attB Bacterial attachment site 
attP Phage attachment site 
βgal β-galactosidase 
Bam Bag of marbles 
Bambi BMP and activin membrane-bound inhibitor 
bHLH basic helix loop helix 
BMP Bone morphogenetic protein 
Bnl Branchless 
bp Base pairs 
BRE BMP response element 
Btl Breathless 
CAF1 Comparative Assembly Freeze 1 
cDNA Complementary DNA 
CPRG Chlorophenol Red-β-D-galactopyranoside 
CtBP C-terminal binding protein 
Cv2 Crossveinless-2 
Dad Daughters against Decapentaplegic 
dARNT Drosophila aryl hydrocarbon receptor nuclear translocator 
dATP Deoxyadenosine triphosphate 
DBD DNA binding domain 
dCTP Deoxycytidine triphosphate  
dGTP Deoxyguanosine triphosphate 
dIdC Deoxyinosinate-Deoxycytidylate 
Dm Dorsomorphin 
DMEM Dulbecco's Modified Eagle's Medium 
DNA Deoxyribonucleic acid 
dNTP Deoxynucleotide triphosphate 
Doc Dorsocross 
Dpp Decapentaplegic 
DTT Dithiothreitol 
dTTP Deoxythimidine triphosphate 
E. coli Escherichia coli 
EBF Early B cell factor 
ECL Enhanced chemiluminescence 
EDTA Ethylenediaminetetraacetic acid 
EGF Epidermal growth factor 
EGTA Ethylene glycol-bis-(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid 
Elb Elbow B 
List of Abbreviations 
 
 
 
7
EMSA Electrophoretic Mobility Shift Assay 
En Engrailed 
Eve Even skipped 
FGF Fibroblast growth factor 
Fos FBJ/FBR osteosarcoma (FBJ/FBR are murine sarcoma viruses) 
Ftz Fushi tarazu 
GAL4 Due to its function as a regulator of yeast galactose metabolism 
GATA GATA binding factor 
Gbb Glass bottom boat 
GDNF Glial-cell-derived neurotrophic factor 
GFP Green fluorescent protein 
Gsb Gooseberry 
GST Glutathione S-Transferase 
HASE Hyperactivated Activating/Silencer Element 
HEK Human embryonic kidney 
HEPES 4-(2-Hydroxyethyl)-1-piperazine-1-ethanesulfonic acid 
Hh Hedgehog 
Hiw Highwire 
HRP Horse radish peroxidase 
Hsp70 Heat shock protein 70 
Id Inhibitor of differentiation 
Indy I’m not dead yet 
IP Immunoprecipitation 
JNK c-Jun N-terminal kinase 
Jun Japanese ju-nana (“17”), isolated from Avian sarcoma virus 17 
Kni Knirps 
Knrl Knirps-related 
lacZ Lactose operon gene Z 
LB Lysogeny broth 
Lef Lymphoid enhancer-binding factor 
Mad Mothers against Decapentaplegic 
MAPK Mitogen-activated protein kinase 
MCS Multiple cloning site 
Med Medea 
MH1/MH2 Mad homology 1/2 
MIS Müllerian Inhibitory Substance 
NASE Nullified Activating/Silencer Element 
NF-κB Nuclear factor κ B 
NLS Nuclear localization sequence 
Nub Nubbin 
OAZ Olf-1/EBF associated zinc finger 
Olf-1 Olfactory neuron-specific transcription factor 1 
Omb Optomotor-blind 
PAS Per, ARNT, Sim 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PFA Paraformaldehyde 
Pfu Pyrococcus furiosus 
Pnr Pannier 
POU Pit, Oct, Unc 
PPARγ2 Peroxisome proliferator-activated receptor γ2 
List of Abbreviations 
 
 
 
8
Prd Paired 
Put Punt 
Race Related to angiotensin-converting enzyme 
RE Response element 
RNA Ribonucleic acid 
RT Room temperature 
Runx2 Runt related gene 2 
Sal Spalt 
Sax Saxophone 
SBE Smad binding element 
Scw Screw 
Sd Scalloped 
SDS Sodium dodecylsulfate 
SE Silencer Element 
Shn Schnurri 
Ski Sloan-Kettering virus 
Sma Small body size 
Smad Sma and Mad 
Smurf Smad ubiquitin regulatory factor 
Sog Short gastrulation 
Sp1 Sephacryl and phosphocellulose protein 1 
SV40 Simian virus 40 
Taq Thermus aquaticus 
TBE Tris-Borate-EDTA buffer 
TCF T-cell-specific factor 
TGF Transforming growth factor 
Tkv Thick veins 
TNF-α Tumor necrosis factor α 
Trh Trachealess 
Tris Tris(hydroxymethyl)aminomethane 
UAS Upstream Activation Sequence 
Ubx Ultrabithorax 
USF Upstream stimulatory factor 
Vg Vestigial 
VP16 Virion polypeptide 16 
Wg Wingless 
Wit Wishful thinking 
Wt Wild type 
XGal 5-Bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
Xvent2 Named after its ventral expression in the Xenopus embryo 
Zen Zerknüllt 
 
 
Abbreviations for measurement units were used as specified by the Système International. 
Aminoacids were abbreviated using the single- or triple-letter code, nucleotides using DNA 
codon letters. 
 
Abstract 
 
 
 
9
3 Abstract 
The TGF-β family member Decapentaplegic (Dpp) is a key regulator of patterning and 
growth in development of Drosophila. Binding of Dpp to its receptors triggers the activation 
of the intracellular Smad pathway. It has recently been shown that Dpp signalling represses 
genes in several tissues by direct binding of the Smad proteins Mad and Medea and the 
recruitment of the nuclear zinc finger protein Schnurri to small regulating sequences called 
Silencer Elements (SEs). A key target of this SE-mediated repression is the brinker gene. 
Brinker is the default repressor of the Dpp signalling pathway and its removal is a prerequisite 
for transcriptional activation of most of the Dpp target genes. 
To address the question if there is, analogous to the SE-mediated repression, also a simple, 
not tissue-specific mechanism to activate target genes, we analyzed the regulation of dad. The 
dad gene encodes the only Drosophila inhibitory Smad and is a potential direct target of Dpp 
signalling. We identified the minimal enhancer of dad and discovered a short motif that we 
called Activating Element (AE). The sequence of the AE is closely related to the one of the 
SE, but differs in important nucleotides. As a consequence, the AE cannot recruit the 
repressor Schnurri. We demonstrated that the AE integrates both repressive input by Brinker 
as well as activating input by Mad and Medea. After characterization of the AE and 
elaboration of a consensus sequence, we were able to predict and successfully identify 
functional AEs in enhancers of other known (and hitherto unknown) direct target genes of 
Dpp. This is the first description of an activating Dpp-response element that is not restricted 
to a distinct enhancer and marks a general mechanism by which Dpp can activate target 
genes. 
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4 Introduction 
 
The transition from unicellular organisms to multicellular life forms and the evolvement of 
specialized cell functions, complex tissues and whole organs required the establishment of a 
new level of cell-cell communication. While unicellular eukaryotes such as yeast cells are 
able to respond to signal molecules secreted by other cells, they still remain autonomous. The 
behavior of a single cell within a complex organism, however, has to be tightly regulated at 
all times to meet the needs of the organism and ensure its survival. Whenever an individual 
organism successfully arises from a single cell, it is the end result of an amazingly large 
number of events. But surprisingly, the number of signalling pathways across the animal 
kingdom that orchestrate these events is rather limited. They include the highly conserved 
signalling pathways of Hedgehog, Wnt, Notch, Jak/STAT, nuclear hormones, receptor 
tyrosine kinases as well as TGF-β. 
4.1 The TGF-β superfamily 
Transforming growth factor β (TGF-β) was first described as a polypeptide product, secreted 
by sarcoma-virus-transformed tumor cells (de Larco and Todaro, 1978; Moses et al., 1981; 
Roberts et al., 1981), that was able to transform normal fibroblasts and induce soft agar 
colony formation. Soon it was discovered that TGF-β could also be isolated from non-
pathological tissues and important roles were found within a vast variety of physiological 
processes, including development, wound healing and diseases such as fibrosis and cancer. 
Meanwhile, more than thirty members have been assigned to the mammalian TGF-β family, 
which can also be termed a superfamily, because their members form families themselves (see 
Fig. 4.1). Proteins of the TGF-β superfamily share high homology of a carboxy-terminal 
polypeptide proteolytically processed from a larger precursor and act as secreted dimers. 
Besides the TGF-β proteins, the TGF-β superfamily includes the Activins, Inhibins, the 
Müllerian inhibiting substance and the bone morphogenetic proteins (BMPs), that were 
initially identified as substances promoting bone growth (Wozney et al., 1988). Furthermore, 
proteins such as the Glial-cell-derived neurotrophic factor (GDNF) can be considered 
distantly-related members of the superfamily, as they share some homologies with TGF-β 
ligands, but act via different receptors. Figure 4.1 shows the mammalian members of the 
TGF-β family (not all of them are listed) and also a selection of members from other species. 
It becomes obvious that, for instance, BMP2 and BMP4 are not only closely related to each 
other, but also to the Drosophila homolog Decapentaplegic (Dpp). Their molecular function is 
so well conserved that the early embryonic phenotype of dpp mutants can be rescued by a 
BMP4 transgene (Padgett et al., 1993). Besides Dpp, the best characterized TGF-β family 
ligand in Drosophila, six more members of the TGF-β family are known in the fruit fly. 
Screw (Scw) and Glass bottom boat (Gbb) belong as Dpp to the BMP family, dActivin and 
Dawdle (Daw; formerly known as the Activin-like-protein Alp) are members of the Activin 
family, and two more ligands, Maverick (Mav) and Myoglianin (Myo), have not been 
assigned to a specific family, since they share homologies with different TGF-β subfamilies 
(Parker et al., 2004). Interestingly, Drosophila seems to lack a bona fide TGF-β ortholog. 
For a more elaborate overview of the TGF-β family, see Derynck and Myazono (2007). 
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4.2 The TGF-β signalling pathway 
Members of the TGF-β family signal through the structurally similar type I and type II 
serine/threonine kinase receptors. Despite the large number of ligands, the number of 
receptors is limited. In vertebrates, seven type I and five type II receptors (also termed 
Activin-receptor-like kinases ALKs) are known. Each ligand binds to one or more 
characteristic combinations of type I and type II receptor (Feng and Derynck, 2005; Shi and 
Massague, 2003; ten Dijke and Hill, 2004). In Drosophila, five TGF-β receptors have been 
found, three type I receptors (Thickveins (Tkv), Saxophone (Sax) and Baboon (Babo)) and 
two type II receptors (Punt (Put) and Wishful thinking (Wit)). Whereas Tkv and Sax are 
restricted to the BMP pathway, Baboon acts in the Activin pathway (compare Fig. 4.7). The 
type II receptors, however, are not restricted to one of the pathways (Pyrowolakis et al., 
2007). 
Binding of the dimeric ligand to the receptors triggers the formation of a complex of at least 
two pairs of type I and II receptors, in which the type II receptor is able to phosphorylate a 
glycin/serine rich juxtamembrane region of the type I receptor. This phosphorylation is 
required and sufficient for activation of the pathway. Single point mutations within the type I 
receptor can mimic this phosphorylation and thus activate the pathway independent of ligand 
binding (Wieser et al., 1995). A widely used tool in Drosophila, the constitutively activated 
type I Dpp receptor TkvQ253D, is based on this observation (Nellen et al., 1996). 
Figure 4.1 
Overview of the TGF-β superfamily. The relationships 
shown are based on the conservation of the mature carboxy-
terminal polypeptide. The TGF-β superfamily can be further 
divided into subfamilies as the member-rich BMP family. 
Besides human proteins, particular closely-related ligands 
from other species are shown. The membership of GDNF is 
controversial, since it does not bind to the classic TGF-β
receptors.  
Figure modified from Gilbert (2000) and partially based on 
the work of Hogan (1996). 
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The multiple phosphorylation of the type I receptor dramatically raises the binding efficiency 
of cytoplasmatic effector proteins, the so-called R-Smads. Smad is a composite name of the 
C. elegans protein Sma and the first Smad family member Drosophila Mad. Mad stands for 
Mothers against Dpp, as it was identified in a genetic screen for maternal effectors of Dpp 
activity (Sekelsky et al., 1995). 
 
 
 
Three classes of Smads can be distinguished, the receptor-activated Smads (R-Smads), the 
common mediator Smads (Co-Smad) and the inhibitory Smads (I-Smads). R-Smads bind to 
the phosphorylated type I receptor and become themselves phosphorylated at two C-terminal 
serine residues. The Smad-receptor interaction is facilitated by auxiliary proteins such as 
SARA, the Smad anchor for receptor activation (Tsukazaki et al., 1998) and enhanced by 
broccoli consumption (Traka et al., 2008). Upon phosphorylation, the R-Smad dissociates 
from the receptor and two R-Smads form a (preferentially) heterotrimeric complex with one 
Co-Smad. However, also the formation of Smad dimers and complexes other than that of two 
R-Smads and one Co-Smad was observed and seems to be of physiological relevance (Feng 
and Derynck, 2005). By binding to components of the nuclear pore complex, the Smads 
Ligand
Type I Rec. Type II Rec.
Co-Smad
R-Smad
I-Smad Dad Smad6Smad7
Co-Smad
pR-Smad
Co-SmadCo-Factor
pR-Smad
Dpp, Gbb, Scw
Tkv, Sax
Mad
Medea
BMP pathway
Drosophila
Put, Wit
BMP and TGF-β
sub-family ligands
7 Type I Rec.
Smad 1/5/8
Smad 2/3
Smad4
BMP/TGF-β pathway
Vertebrates
5 Type II Rec.
General Pathway
cytoplasm
nucleus
Figure 4.2 
Overview of the TGF-β signalling pathway in general and the BMP pathway in Drosophila. Upon formation of a multimeric ligand-
receptor complex, the type I receptor is phosphorylated and can then phosphorylate the cytoplasmatic R-Smad. The activated R-Smads bind 
to the Co-Smads and the heteromeric complex shuttles into the nucleus where it interacts with transcriptional regulators, activators and 
repressors and controls target expression in a sequence-specific manner. Drosophila lacks a TGF-β homolog, but possesses a BMP and 
Activin pathway. The three ligands Decapentaplegic (Dpp), Glass bottom boat (Gbb) and Screw (Scw) can bind to the type I receptors
Thickveins (Tkv) and Saxophone (Sax) and the type II receptors Punt (Pit) and Wishful thinking (Wit). Unlike in vertebrates, every class of 
Smads has only one representative in the Drosophila BMP pathway: the R-Smad Mothers against Decapentaplegic (Mad), the Co-Smad 
Medea and the I-Smad Daughters against Decapentaplegic (Dad). The function of another R-Smad found in the fruit fly, dSmad2, is limited 
to the Activin pathway. 
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shuttle into the nucleus, where they are able to recruit transcriptional regulators and affect 
expression of target genes in a cell-type and signal specific manner. The diversity of 
transcription factors that Smad protein can interact with is remarkable (for a comparative 
overview see Feng and Derynck, 2005). The forkhead transcription factor FAST/FoxH1 was 
the first one reported to cooperate with Smads (Chen et al., 1997). Meanwhile, a plethora of 
DNA-binding co-regulators has been identified, including members of the nuclear receptor, 
homeodomain protein or Runx family, as well as Jun/Fos proteins, zinc finger transcription 
factors, member of the Wnt pathway and many others. Since Smad proteins recognize only 
very simple motifs (see below), the recruitment of these various DNA-binding transcription 
factors is essential for specific binding to cis-regulatory elements and thus regulating the 
expression of target genes in a cell- and signal-specific manner. 
R-Smads and Co-Smads are both composed of two characteristic protein domains, the MH1 
and MH2 domains, that are linked by a less conserved polypeptide sequence (Fig. 4.3). 
However, Co-Smads lack the C-terminal SXS motif of R-Smads that becomes phosphorylated 
by the type I receptor. While the MH1 domain is involved in DNA binding, the MH2 domain 
is responsible for interaction with the receptor, nuclear import via binding to nucleoporins and 
oligomerization (Shi and Massague, 2003). Furthermore, both MH1 and MH2 domain have 
been shown to interact with numerous nuclear proteins. Although the linker region is not well 
conserved, it contains several regulatory elements, including the PY motif, which binds 
ubiquitin ligases, and sites for phosphorylation (Heldin, 2007). The N-terminus of I-Smads 
shares only very weak similarity with the MH1 domain, while the MH2 domain is highly 
conserved. I-Smads are considered the antagonists of the pathway, terminating the signal in 
several ways (Shi and Massague, 2003). By competing with R-Smads for receptor binding, 
they inhibit their phosphorylation. Furthermore, I-Smads mediate ubiquitination and 
degradation of the receptor complex by E3-ubiquitin ligases (Smurfs) and are able to recruit 
specific phosphatases (Shi et al., 2004). Although they lack the MH1 domain, evidence for 
additional roles at the transcriptional level has been found (Feng and Derynck, 2005). 
 
 
Figure 4.3 
Structure of the Smad proteins. The MH1 and MH2 domains are conserved among the Smad proteins (light pink indicates conservation
only among R-Smads). Whereas the MH1 domain is involved in DNA-binding, the MH2 domain is required for interaction with the receptor 
and SARA, oligomerization and nuclear import. Both MH1 and MH2 domain are involved in protein-protein binding. The less conserved 
linker region is substrate for ubiquitination and phosphorylation by kinases of other signaling pathways. Only the R-Smads possess the SXS 
motif phosphorylated by the type I receptor. I-Smads lack the MH1 domain, but there is evidence that they can also be involved in 
transcriptional regulation. While there is only one Co-Smad in vertebrates (Smad4), five R-Smads can be found. Smad1, Smad5 and Smad8 
transduce BMP signalling, whereas Smad 2 and Smad 3 act downstream of TGF-β and Activin. Interestingly, Smad 2 contains an insert in 
the β hairpin of the MH1 domain which inhibits direct DNA binding. Two inhibitory Smads are known, Smad6 and Smad7, that are able to
antagonize signalling by competing with R-Smads, recruiting phosphatases and inducing proteasome-mediated degradation of the activated 
receptor complex. While Smad7 counteracts both BMP and TGF-β signalling, Smad6 preferentially antagonizes BMP signaling. Figure 
modified from ten Dijke and Hill (2004). 
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4.3 Dpp signalling in Drosophila 
The few numbers of ligands, receptors and Smad proteins as well as the diversity of available 
genetic tools make Drosophila an excellent model system to examine the BMP/TGF-β 
pathway. Most work so far has been done in the context of the BMP2/4 homolog 
Decapentaplegic (Dpp). The name Decapentaplegic (fifteen defects) refers to the large 
number of abnormalities found in the imaginal discs of dpp mutants (Spencer et al., 1982) and 
already gives a hint of its important role in development. Amongst other processes, Dpp is 
required during oogenesis, for formation of the dorsal-ventral axis of the embryo, patterning 
of the ectoderm, visceral mesoderm and endoderm, development of organs as heart, gut and 
trachea as well as growth and patterning of the larval imaginal discs, that give rise to adult 
appendages. 
4.3.1 Dpp acts as a morphogen 
A very striking feature of Dpp is its function as a morphogen - an extracellular signalling 
molecule able to induce changes in distant cells in a concentration-dependent manner 
(Wolpert, 1969). Secreted ligands of several signalling pathways have been identified as 
morphogens, namely TGF-β, Hedgehog, Wingless/Wnt, Epidermal growth factor (EGF) and 
Fibroblast growth factor (FGF) 
proteins. They were shown to elicit 
gradient-dependent responses in 
various tissues and organisms. Sonic 
hedgehog, a vertebrate member of the 
hedgehog family, is an important 
organizer of the developing neural 
tube (Ericson et al., 1997), and a 
concentration gradient of BMP-4 is 
responsible for dorso-ventral 
patterning of the early Xenopus 
embryo mesoderm (Dosch et al., 
1997), to mention just two examples. 
One of the best established models for 
the role of a morphogen gradient in 
growth and patterning is the 
Drosophila wing imaginal disc, where 
Dpp acts as a morphogen (reviewed in 
Affolter and Basler, 2007; Tabata, 
2001). Dpp is secreted by cells within 
a narrow stripe along the anterior-
posterior compartment boundary (Fig. 4.4). From this central domain, a Dpp gradient is 
established that could be visualized by the expression of a Dpp-GFP fusion protein (Entchev 
et al., 2000; Teleman and Cohen, 2000). Extracellular matrix components as the heparan 
sulphate proteoglycans (HSPGs) Dally and Dally-like have been shown to facilitate the 
transport not only of Dpp (Belenkaya et al., 2004) but also other morphogens as Wingless 
(Lin and Perrimon, 1999; Tsuda et al., 1999). However, it is not yet clear how the Dpp 
gradient is generated. The two main theories propose planar transcytosis (Entchev et al., 
2000) and facilitated diffusion, with recent results favoring the latter (Belenkaya et al., 2004). 
As expected from a morphogen, Dpp is able to regulate target gene expression in the disc in a 
concentration- and thus distance-dependent manner. This feature was initially demonstrated 
Anterior
Posterior
Posterior
Figure 4.4 
Formation of the dpp expression domain. The wing imaginal disc is 
divided into an anterior and posterior compartment, as a result from its 
position in the larva. The posterior compartment expresses engrailed (en),
whereas the anterior compartment does not. Cells positive for en secret the 
signalling protein Hedgehog (Hh), which induces the expression of dpp. 
But only cells negative for en are able to respond to Hh. As a consequence, 
Dpp is expressed only along the anterior-posterior border in cells of the 
anterior compartment that are still in range of the secreted Hh ligand 
(Zecca et al., 1995). 
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by analysis of the Dpp target genes optomotor-blind (omb) and spalt (sal) (Nellen et al., 
1996). Both genes encode a transcription factor (a T-box family member and zinc finger 
protein, respectively) and are expressed as a stripe of different width along the anterior-
posterior border in the wing imaginal disc (see Fig. 4.5). Expression of omb and sal reporter 
constructs was shown to be absent in tkv clones and ectopically upregulated not only in cells 
expressing the constitutively active Dpp receptor TkvQD, but also in cells that were adjacent to 
cells expressing Dpp. Furthermore, omb and sal reacted to different dosages of TkvQD. At this 
time little was known about the molecular interactions within the Dpp pathway, the 
Drosophila Smads Mad and Medea had just been identified. The observation that the 
expression domain of omb was wider than that of spalt could be easily explained with a 
higher sensitivity of omb to direct Dpp signalling. 
However, this view changed dramatically with the discovery of the transcriptional repressor 
Brinker (Campbell and Tomlinson, 1999; Jazwinska et al., 1999a; Minami et al., 1999). The 
transcription of brinker (brk) was shown to be repressed by Dpp. As a consequence, Brinker 
displays an opposite concentration gradient, with high levels of brk expression in lateral 
regions and no expression in the central domain (Fig. 4.5). Additionally, it was revealed that 
Brinker represses Dpp targets such as omb and sal. It turned out that omb is not even activated 
by Dpp, but by an unknown factor, and only repressed by Brinker. Thus, the extracellular Dpp 
gradient is transformed into a reverse nuclear Brinker antigradient, which then (partially in 
concert with Smad-transduced Dpp signalling, as shown for sal) delivers positional 
information and finally regulates the expression domain of the respective target genes. 
Figure 4.5 
Regulation of Dpp target genes in the wing imaginal disc. Dpp (green) is expressed and secreted by cells within a narrow stripe in the 
central domain of the wing disc and forms an extracellular gradient along the anterior-posterior axis. One of its main functions is the 
downregulation of brinker, which encodes a nuclear repressor. Brinker (pink) levels are high in lateral regions of the disc and low towards 
the center, where Dpp levels are highest. Brinker target genes as omb (beige) and sal (orange) exhibit individual sensitivity to Brinker levels 
and are consequently expressed in different width. omb is resistant to high amounts of Brinker and is thus expressed in a broader domain,
whereas sal is already repressed by low levels of Brinker and is expressed in a rather narrow stripe. 
Dpp
Brinker
omb sal
Anterior Posterior
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4.3.2 The role of Brinker 
Brinker is a nuclear protein with a helix-turn-helix DNA recognition motif structurally similar 
to the Pax6 paired-domain and with weak homology to the homeodomain (Cordier et al., 
2006; Jazwinska et al., 1999a). No Brinker homolog is known in vertebrates. As a sequence-
specific repressor, Brinker preferentially binds to the GC-rich sequence (T)GGCGCC 
(Sivasankaran et al., 2000; Zhang et al., 2001). The repression of brk is one of the key events 
in cells exposed to Dpp signalling and a prerequisite for activation of most of the Dpp target 
genes. Brinker is a major antagonist of the Dpp pathway and is capable of repressing genes 
upregulated by Dpp in the embryo as well as in larval tissues (Campbell and Tomlinson, 
1999; Jazwinska et al., 1999a; Jazwinska et al., 1999b; Minami et al., 1999). With the 
discovery of Brinker, it became obvious that genes like omb, that were believed to be direct 
targets of Dpp, were actually derepressed by Dpp via removal of Brinker. 
Interestingly, there seem to be two mechanisms by which Brinker can repress its target genes. 
First, it is able to recruit the co-repressors CtBP (C-terminal binding protein) and Groucho 
(Hasson et al., 2001; Zhang et al., 2001). Second, it was shown that the Brinker protein 
competes with transcriptional activators for binding to overlapping DNA motifs - not only 
with Smads in the case of enhancers of vestigial (vg), Ultrabithorax (Ubx) and zerknüllt (zen) 
(Kirkpatrick et al., 2001; Rushlow et al., 2001; Saller and Bienz, 2001), but also with other, 
unknown activators as in the case of omb (Sivasankaran et al., 2000). 
 
 
 
 
Although the Brinker DNA-binding domain with its helix-turn-helix motif does not show any 
sequence homology to the Smad MH1 domain with its DNA-binding β hairpin (Chai et al., 
2003; Shi et al., 1998), the two proteins are able to bind to very similar DNA motifs. The 
short Smad binding element (SBE) AGAC was identified as the minimal sequence able to 
recruit a vertebrate Smad MH1 domain (Shi et al., 1998; Zawel et al., 1998). Due to the high 
conservation of the MH1 domains it was proposed that all Smads could recognize the SBE. 
However, already before it had been reported that the Drosophila Smad Mad was able to bind 
also to GC-rich sequences (Kim et al., 1997). These results were soon confirmed for 
vertebrate Smads (Ishida et al., 2000; Labbe et al., 1998) and might be due to an alternative 
way of interaction of DNA and MH1 domain (Shi and Massague, 2003). 
Considering the regulation of Dpp target genes by Smads and Brinker, three classes of genes, 
respectively enhancers, can be distinguished (Fig. 4.7). Class I includes genes that are 
repressed by Brinker, but not directly activated by the Dpp pathway. One example is the 
before-mentioned omb gene (Sivasankaran et al., 2000). Most genes fall into Class II. They 
are directly activated by the Dpp pathway and also subjected to Brinker-mediated repression. 
Examples are spalt (Barrio and de Celis, 2004; Marty et al., 2000) or zen (Rushlow et al., 
2001). Genes of this class can be further subdivided in genes whose regulation is based on 
Figure 4.6 
Structure of the Brinker protein. Brinker has a total size of 704 amino acids. In vitro experiments led to the identification of an N-terminal 
DNA-binding domain with slight homology to the homeodomain. The smallest fragment reported to be able to bind to DNA in an
electrophoretic mobility shift assay consisted of amino acids 44 to 99 (Saller and Bienz, 2001). The repression domain was mapped to amino 
acids 369 to 541 and includes two binding motifs for interaction with the co-repressors CtBP (PMDLSLG at position 377) and Groucho 
(FKPY at position 461) (Hasson et al., 2001). 
1
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competition of Smads and Brinker and genes where sites of Smad and Brinker input are 
spatially separated. Class III finally is made up of genes that are activated by the Dpp 
pathway but do not fall under repression of Brinker. This is the case for Race (Related to 
angiotensin converting enzyme), a gene expressed in the amnioserosa of the early embryo, 
where Dpp signalling is strongest (Rusch and Levine, 1997). The Race enhancer is activated 
by direct binding of Smads, but is independent of Brinker (Ashe et al., 2000; Wharton et al., 
2004; Xu et al., 2005). 
 
 
4.3.3 Regulation of Brinker 
With the discovery of Brinker as the default repressor of the Dpp pathway, it became obvious 
that downregulation of the brinker gene is crucial for activation of a majority of Dpp target 
genes. The question remained how this happens at the molecular level. Genetic studies 
revealed that, besides the members of the Dpp pathway, the zinc finger transcription Schnurri 
(Shn) is involved in the regulation of brinker expression (Marty et al., 2000). shn had been 
originally identified in a screen for genes on the second chromosome causing embryonic 
lethality (Nüsslein-Volhard et al., 1984) and was subsequently linked to the Dpp pathway 
(Arora et al., 1995; Grieder et al., 1995; Staehling-Hampton et al., 1995). The phenotype of 
shn mutants resembles the phenotype of mutants with a defective Dpp signalling pathway. As 
Figure 4.7 
Classes of Dpp/Brinker target genes. In the absence of Dpp signalling, Brinker is expressed and able to downregulate target genes. 
Activation of the Dpp pathway leads to efficient repression of brinker by a complex of Mad, Medea and the co-repressor Schnurri. Three 
classes of genes that are regulated by Brinker and the Dpp pathway can be distinguished: I) Genes that are repressed by Brinker and 
upregulated upon removal of Brinker by a non-Smad activator. II) Genes that are repressed by Brinker and activated by Smads and co-
activators. III) Genes that are not repressed by Brinker, but activated by the Dpp pathway.  
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a result of genetic epistasis experiments Schnurri was placed downstream of Dpp; its 
molecular function, however, remained obscure until it was clearly associated with repression 
of brinker. 
Later studies have shown that the enhancer of brinker has a modular character (Müller et al., 
2003; Yao et al., 2008), with elements able to drive expression of a reporter gene ubiquitously 
throughout the wing imaginal discs by so far unknown activators, and smaller Dpp-responsive 
repressive elements, named silencers. Biochemical analysis revealed that a complex of Mad, 
Medea and SchnurriCT (a truncated version of the Schnurri protein) specifically binds to the 
silencer (Müller et al., 2003). Furthermore, it turned out that the function of the silencer was 
not restricted to the brk enhancer. It could confer Dpp responsiveness also in heterologous 
situations, for example when fused to an enhancer active in the blastoderm-stage embryo 
(Fig 4.8). Subsequent dissection led to identification of a minimal silencer, the 16bp Silencer 
Element (SE) that was still able to recruit the Mad/Medea/ShnCT complex and confer Dpp-
mediated repression in vivo (Pyrowolakis et al., 2004). Mutation analysis of the SE resulted in 
the consensus sequence GRCGNC(N)5GTCTG (Fig. 4.9). By using differently tagged Smad 
proteins, it has been shown that a tripartite complex of two Mad proteins and one Medea 
protein binds to this sequence (Gao et al., 2005). This is a prerequisite for the recruitment of 
Schnurri into this complex, since SchnurriCT does not bind to the SE in the absence of the 
Smad proteins. Each of the two Mad proteins binds to one GNC motif within the GRCGNC 
site, while Medea binds to the GTCTG site, that resembles the classical Smad binding 
element AGAC (Gao and Laughon, 2007; Gao et al., 2005; Pyrowolakis et al., 2004). The 
distance and the base composition have no influence on the binding of the Smad tripartite 
complex and can be extensively varied (Gao and Laughon, 2007). However, only when the 
two Smad binding sites are separated by exactly five nucleotides, SchnurriCT can be recruited 
into the complex. Consequently, SEs with mutated linker length do not exert any repressive 
function in vivo (Pyrowolakis et al., 2004). Scanning the Drosophila genome for the SE 
delivered 350 hits, with the by far highest accumulation in the vicinity of the brk gene (ten 
hits). This could reflect the importance of fine-tuning the brk expression by the Dpp gradient. 
In addition, functional silencer elements have been identified in the enhancers of the 
embryonic segment-polarity gene gooseberry (gsb) and bag of marbles (bam), which is 
involved in germline stem cell maintenance (Pyrowolakis et al., 2004). 
Figure 4.8 
Flexible function of the SE. (A) An activating element within the brk enhancer (brkE) drives expression of a reporter gene throughout the 
whole wing imaginal disc. If a small repressive modul from the brk enhancer, the silencer brkS, is fused back to the activator, the expression 
is reduced within regions of high Dpp levels and resembles endogenous brinker expression. (B) The function of the silencer is not limited to 
brk and the wing disc. The eve stripe 2 enhancer of the pair-rule gene even-skipped is active in the early embryo (Small et al., 1992). If a brk
silencer is fused to eve2, the enhancer becomes repressed in the dorsal-most domains (red arrow), where Dpp levels are highest. Figures 
based on Pyrowolakis et al. (2004) and Müller et al. (2003). 
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4.3.4 The role of Schnurri 
Although shn encodes a huge protein of 2529 amino acids, it has been shown that the C-
terminal 641 residues (termed SchnurriCT) are required and sufficient to form a complex with 
Mad/Medea and the SE in vitro and to repress a brk reporter gene in the Drosophila embryo 
(Müller et al., 2003) – which raises the question for the function of the rest of the protein. 
Eight putative zinc finger domains can be found within the Schnurri protein, seven of the 
Cys2His2 type and one of the Cys2HisCys type (zinc finger 3, see Fig 4.10). The C-terminal 
most zinc fingers, a triplet of zinc fingers 6 to 8, make up the complex formation domain of 
SchnurriCT. Additionally, a repression domain was localized to the N-terminus of SchnurriCT 
(Pyrowolakis et al., 2004). One Schnurri homolog in C. elegans, Sma-9, has been reported to 
act in a BMP-related pathway (Liang et al., 2003a). Sma 9 lacks the first three zinc fingers but 
has zinc fingers conserved to the ZF 4/5 pair and the ZF 6/7/8 triplet. Unlike Brinker, 
Schnurri homologs can be found in vertebrates, where they are also termed human 
immunodeficiency virus type I enhancer binding proteins (HIV-EP), major histocompatibility 
complex binding proteins (MBP), positive regulatory domain II-binding factor (PRDIIBF1) or 
κB binding and recognition component (KRC).  
Mammalian Schnurris have been linked to B- and T-cell development (Bachmeyer et al., 
1999; Takagi et al., 2001), adipogenesis (Jin et al., 2006) and bone formation (Jones et al., 
2006), but very little is known about their molecular interactors. Murine Schnurri 3 has been 
shown to participate in TNF (tumor necrosis factor) signalling (Oukka et al., 2002), to interact 
with the transcription factor c-Jun to regulate Interleukin-2 expression (Oukka et al., 2004) 
and to recruit E3 ubiquitin ligases to Runx2, the principal transcriptional regulator of 
osteoblast differentiation (Jones et al., 2006). Although vertebrate Schnurris are widely 
believed to also act in the TGFβ-/BMP pathway, there is only few data available about their 
interaction with Smads. One reported case is the Shn2-mediated induction of PPARγ2, which 
encodes the key transcription factor for adipocyte differentiation, peroxisome proliferator-
activated receptor γ2. Upon stimulation of BMP2, Shn2 enters the nucleus and binds to the 
PPARγ2 promoter in cooperation with Smad1/4 and C/EBPα (CCAAT/enhancer-binding 
protein α) (Jin et al., 2006). Several Smad binding elements (AGAC) were found within the 
promoter, but no sequence resembling the Drosophila SE. In a mobility shift assay, Shn2 was 
not able to bind itself, but fragments including either the first or second pair of zinc fingers 
augmented Smad-DNA interaction. 
The question has to be posed, whether there is a functional SE in vertebrates at all. Strikingly, 
all human Schnurri (hShn) proteins completely lack the ZF 6/7/8 triplet required for 
Figure 4.9 
The repressive SE complex. A flexible Smad triple complex
assembles on the 16bp Silencer Element: two Mad proteins bind
to the “red box” GRCGNC and one Medea protein to the “blue
box” GTCTG. Only when the two sites are separated by exactly
five nucleotides, the repressor Schnurri is recruited into the
complex. No structural data is available and it is not known
whether and how Schnurri interacts with the DNA. However, it
has been shown that the second T in GTCTG is required for
Schnurri recruitment, while the Smad complex still forms when
this nucleotide is mutated (Pyrowolakis et al., 2004). 
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SE/Schnurri/Mad/Medea complex formation in Drosophila, though the other doublets are 
highly and zinc finger 3 partially conserved. It has been shown that the zinc fingers of 
vertebrate Schnurri proteins are implicated in DNA binding. hShn1 was originally identified 
by its ability to bind to the same sites as NF-κB (Maekawa et al., 1989) and recognizes the 
palindromic sequence TGGGGATTCCCCA with its zinc fingers 4 and 5 (Baldwin et al., 
1990). Direct binding to CCC-containing sites has been reported for Schnurri homologs in 
Xenopus (Dürr et al., 2004), and also the zinc finger pairs 1/2 and 4/5 of Drosophila Schnurri 
have been proposed to bind to a palindromic motif GGG(N)5/6CCC similar to the one initially 
identified for hShn1 (Dai et al., 2000). Furthermore, the zinc finger pairs of hShn have been 
shown to interact with Smad1 (hShn1) and Smad1 and Smad4 (hShn2) in 
immunoprecipitation assays (Jin et al., 2006; Yao et al., 2006). This might be due to 
homology with the zinc finger triplet 6/7/8 of Drosophila Schnurri (where ZF7 is dispensable, 
Pyrowolakis et al. (2004)). However, also for Drosophila Schnurri, sequences outside 
SchnurriCT and including the other zinc fingers have been identified as interactors with Mad 
(Dai et al., 2000; Udagawa et al., 2000). It was recently revealed that ubiquitous expression of 
hShn1 rescues the shn mutant phenotype in Drosophila to the same extent as Schnurri and 
that both hShn1 zinc finger pairs are able to form complexes with Smads on a SE-like 
sequence derived from the Xenopus Vent2 promoter (Yao et al., 2006). This was the first 
study where a SE-like element with the same restrictions considering the spacer length could 
be linked to vertebrate Schnurri. It is noteworthy that vertebrate Schnurris could so far only be 
associated with activation (although hShn1 is able to repress a brk reporter in the fly) and the 
question remains, whether Drosophila Schnurri can also act as an activator. There is 
disputable genetic evidence for this (Torres-Vazquez et al., 2001), and the Ubx enhancer 
could be such a case where direct Schnurri binding is responsible for gene activation (Dai et 
al., 2000). 
4.4 Aim of the study 
4.4.1 Search for an SE counterpart 
The discovery of the SE as a DNA motif for recruitment of a Smad-repressor complex and its 
subsequent thorough characterization provided for the first time a sequence that could be used 
to identify new Dpp target genes. The most striking feature of the SE is that its activity is not 
or little temporally and spatially restricted. Genes with functional SEs are effectively 
Figure 4.10 
Conservation of Schnurri. Schnurri has eight zinc fingers, seven of the C2H2 type and one of the C2HC type (ZF 3). ZF 1/2 and ZF 4/5 are 
highly conserved in vertebrate Schnurris as the depicted human Schnurri homologs hShn1 to hShn3, whereas ZF 3 is less conserved and even 
absent in hShn2. ZF 6/7/8 are completely missing. Zinc fingers 4 to 8 are also conserved in the C. elegans Schnurri homolog Sma-9. Sma-9 
possesses two more C-terminal zinc fingers not related to zinc fingers from other species. Shown in blue is the 641aa minimal functional 
Schnurri protein SchnurriCT with its repression domain (striped). 
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repressed by Dpp in various developmental contexts, independent of local co-repressors. No 
other cis-regulatory element conferring Dpp induced responses is known that acts in such a 
universal manner. Few enhancers regulated by the Dpp pathway have been analysed in 
molecular detail. Most of them display several Smad binding motifs and adjacent binding 
sites for locally restricted transcription factors, as Zen for the Race enhancer (Rusch and 
Levine, 1997; Wharton et al., 2004), Tinman itself for the tinman enhancer (Xu et al., 1998) 
or Ubx for the spalt enhancer (Walsh and Carroll, 2007). Due to the enhancer-specific 
composition and arrangement of these sites, it was never possible to deduce any consensus 
sequence or general motif analogous to the SE to identify further genes regulated by the same 
mechanism. Because of their simple nature, single Smad binding sites alone do not allow for 
any reasonable prediction. The four base pairs long SBE, for example, statistically occurs 
every 128 base pairs. But since the two Smad binding motifs within the SE appear in a fixed 
arrangement, the resulting consensus sequence is specific enough to be used in in silico 
screens. The question that rises is, whether there are also other constellations possible that 
recruit activators rather than a repressor. Is there a simple module such as the SE, flexible and 
adaptable to different enhancers, that confers activation instead of repression? The Silencer 
Element was discovered in the regulatory region of brinker, a gene that is strictly repressed 
upon Dpp signalling. If there was an “Activating Element”, chances would be highest to find 
it in the enhancer of a gene that is consequently upregulated in cells with an activated Dpp 
pathway. The prototype of such a gene is dad (daughters against dpp), that encodes the only 
Drosophila inhibitory Smad. The expression of dad is widely induced by Dpp in embryonic 
and larval development (Marty et al., 2000; Torres-Vazquez et al., 2001; Tsuneizumi et al., 
1997), and Dad is able to antagonize Dpp signalling by interaction with the type I receptor 
Thickveins (Inoue et al., 1998). Recently, it has been shown that Dad is restricted to the BMP 
pathway and not able to inhibit the receptor Baboon and thus counteract Activin signalling 
(Kamiya et al., 2008). Although tissue-specific Dad overexpression is a common tool to 
disrupt Dpp signalling, little is known about it functions. However, it is not unlikely that Dad 
makes use of the same mechanisms as the vertebrate I-Smads Smad6 and Smad7 for blocking 
the Dpp pathway (see 4.2).  
4.4.2 Transcriptional regulation of inhibitory Smads 
Although ultimate molecular evidence is missing, dad is believed to be directly activated by 
Dpp and repressed by Brinker. dad expression is absent in tkv- mutant clones in the wing 
imaginal disc (Tsuneizumi et al., 1997) and lacking in shn mutant embryos (Marty et al., 
2000). Embryos mutant for brk display an expanded dad expression pattern (Torres-Vazquez 
et al., 2001). Vertebrate I-Smads have been shown to be directly activated by the TGF-β/BMP 
pathway. The promoter region of the vertebrate dad homolog smad7 is one of the best-
analysed BMP-regulated enhancers. After publication of the Smad binding element (Shi et al., 
1998; Zawel et al., 1998), several groups focused on the search for this SBE and reported the 
existence of a palindromic tandem element GTCTAGAC in the human and mouse smad7 
enhancer that is confering BMP-responsiveness by recruitment of Smad3 and Smad4 (Brodin 
et al., 2000; Denissova et al., 2000; Nagarajan et al., 1999; von Gersdorff et al., 2000). Later, 
the existence of a so-called BMP response element (BRE) with the sequence TGGCGCC 
within the vertebrate smad7 enhancer was reported to recruit Smad1 (Benchabane and Wrana, 
2003; Karaulanov et al., 2004). In addition, this sequence was identified in BMP-target genes 
such as bambi, Ihh (Indian hedgehog), the Id (Inhibitor of differentiation) genes and several 
others (Karaulanov et al., 2004; Korchynskyi and ten Dijke, 2002; Seki and Hata, 2004), often 
in the context TGGCGCC(N)xGTCT(G), which (though acting in an activating manner) 
resembles the SE. A GC-rich BMP response element was also found in the promoter of smad6 
(Ishida et al., 2000). 
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Figure 4.11 
Search for the activating counterpart of the SE. The Dpp pathway 
induces repression as well as activation. But only for repression a 
well-characterized cis-regulatory motif was found that functions in all 
developmental contexts: the Silencer Element. It recruits a complex of 
phosphorylated Mad, Medea and Schnurri not only to the enhancer of 
brinker, but also other genes downregulated upon Dpp signalling. The 
aim of this study was to search for a potential activating counterpart 
of the SE by analyzing the enhancer of dad, a gene widely activated 
by the Dpp pathway. We expected such an “Activating Element” to 
differ in aspects like the composition of the Smad sites or the nature 
of the bound co-factor. 
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Little surprising, the regulation of smad6 and smad7 is not dependent on Smads alone. GATA 
proteins (named after their recognition sequence) have been shown to cooperate with Smad1 
for the activation of smad7 (Benchabane and Wrana, 2003), and adjacent to the SBE, 
(putative) binding sites for several other transcription factors such as EKLF (Erythroid 
Krüppel-like factor, also termed Klf1), USF (Upstream stimulatory factor) and AP1 
(Activator protein 1, a Jun/Fos complex) have been found (Brodin et al., 2000; Karaulanov et 
al., 2004). Sp1, also a member of the KLF family, has been shown to bind to GC-rich 
sequences within the smad7 enhancer (Brodin et al., 2000) and interact with Smads to induce 
expression of smad7 (Jungert et al., 2006). Furthermore, cooperative binding of Smads and 
TFE3 (transcription factor microE3) to so-called E-boxes adjacent to the SBE has been 
implicated in efficient induction of smad7 (Hua et al., 2000). Interestingly, the palindromic 
SBE has also been reported to be important for gene repression and recruits a complex of 
Smad4 and the co-repressor Ski (Denissova and Liu, 2004). The activation of smad6 upon 
stimulation with BMP4 has been shown to depend on the binding of a complex formed by 
Smad1/4 and OAZ (Olf-1/EBF associated zinc finger) (Ku et al., 2006), a common co-factor 
previously shown to be important for Smad-mediated activation of Xenopus Vent2 (Hata et 
al., 2000). Another study identified the Smad co-activator Runx2 (Runt related gene 2) as an 
important regulator of smad6 that was able to either recruit Smad1 for activation or Smurf 1 
for inhibition (Wang et al., 2007). 
4.4.3 Strategy 
Since the regulatory regions of dad had not been investigated before, the initial steps in the 
search for an activating counterpart of the SE included a more detailed genetic analysis of dad 
expression and, in parallel, the identification and characterization of the dad enhancer. The 
latter had to be done by cloning potential enhancer fragments and examining their ability to 
drive a reporter gene in transgenic flies. Further dissection of the dad enhancer was performed 
with the aim to reveal a minimal Dpp/BMP response element able to recruit Smads and confer 
Dpp activity in vitro in biochemical binding 
assays as well as in vivo. Ultimately, the 
universality of the identified “Activating 
Element” would have to be shown by 
demonstrating its function in enhancers of 
other genes known (or so-far unknown) to be 
activated by Dpp. Questions to be answered 
were, by which means an activating cis-
regulatory element would differ from the SE, 
by the constellation of the Smad sites or by 
the recruitment of an activator instead of the 
repressor Schnurri.  
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5 Material and Methods 
5.1 Generation of transgenic flies 
5.1.1 Cloning of reporter constructs 
In general, standard molecular biology techniques were applied for all cloning procedures 
(Sambrook and Russell, 2001). Initial enhancer dad enhancer constructs were inserted into the 
P-element transformation vector px27 (Segalat et al., 1994). Enhancer constructs from other 
genes, Dad13 mutants and all 5xAE and derived constructs were inserted into the attBlacZ 
vector. The attBlacz vector was constructed by cutting out the UAS-Hsp70-MCS (via 
SphI/XbaI) from the  pUASTattB vector (Bischof et al., 2007) and replacing it with the MCS-
lacZ cassette (cut out via SphI/SpeI) of the pH-Pelican vector (Barolo et al., 2000).  
5.1.1.1 Polymerase chain reaction (PCR) 
Putative enhancer fragments were cloned from genomic DNA with a PCR-based approach. 
Primers of approximately 21nt length were used to introduce restriction sites at the 5’ and 3’ 
end. By default, an XbaI and Asp718 site was generated, unless one of the sites occurred 
within the enhancer fragment. PCR reactions were carried out in a T3 thermocycler 
(Biometra), typically following this cycle: 
94°C 1min 30sec 
94°C 20sec 
50°C 20sec      3x 
72°C 1min per kb 
94°C 20sec 
58°C 20sec      30x 
72°C 1min per kb 
72°C 5min 
 8°C ∞ 
The size and quantity of the PCR products were visualized via agarose gel electrophoresis. 
Subsequently, the DNA was purified using a QiaQuick Gel Extraction Kit (Qiagen). 
 
PCR reaction 0.5µl Taq polymerase (NEB) 
 0.5µl Pfu polymerase (Stratagene) 
 5µl 10x Thermopol buffer (NEB) 
 5µl 2mM dNTP mix 
 5µl 10µM forward primer 
 5µl 10µM reverse primer 
 1-3µl template 
 H2O to 50µl 
5.1.1.2 Restriction digest 
PCR products and the respective plasmid were digested for at least one hour at 37°C in a 
volume of 20µl with the appropriate restriction enzymes and buffers (NEB or Roche). The 
digested DNA was separated by agarose gel electrophoresis and purified using a QiaQuick 
Gel Extraction Kit (Qiagen). 
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5.1.1.3 Ligation and transformation 
Vector and insert DNA were ligated in a ratio of approximately 1:3 in a volume of 15µl over 
night at 16°C with T4 ligase (NEB). To generate 5xAE and derived constructs, 1µl of 100µM 
double-stranded oligonuculeotides with adequate overhangs was used. 
For transformation, chemo- or electrocompetent E. coli bacteria of the strain XL1 Blue 
(Stratagene), XL10 Gold (Stratagene) or Top10 (Invitrogen) were used. Chemotransformation 
was performed by incubating 15µl ligation reaction with 100µl competent cells on ice for 
20min, 45sec heat shock at 42°C and 2min incubation on ice. Electrotransformation was 
performed using 1µl ligation reaction with 40µl competent cells in a 0.1cm Gene Pulser 
cuvette (Biorad) in a Gene Pulser (Biorad) at 25μF, 1.8kV and 200Ω. 
After transformation, cells were propagated in 1ml LB medium (Sambrook and Russell, 2001) 
without antibiotics at 37°C, transferred to LB plates with 100µg/ml ampicillin and allowed to 
grow over night at 37°C. Single colonies were picked and the plasmids isolated using a 
GenElute Plasmid Miniprep (Sigma). The constructs were tested by PCR or restriction digest. 
Positive results were verified by automated sequencing with an ABI Prism 310 Genetic 
Analyzer (Applied Biosystems). For injection into Drosophila embryos, larger bacterial 
cultures were inoculated and the plasmids isolated using a Plasmid Midi Kit (Qiagen) or a 
GenElute Plasmid Midiprep (Sigma). 
Figure 5.1 
Partial map of pUAST-BrkVP16. Shown are the five optimized GAL4 binding sites (5xUAS), the minimal Hsp70 promoter, the polylinker
with unique restriction sites and the SV40 polyadenylation site of the pUAST vector. A fragment containing the first 300bp of the brinker
gene (green), a nuclear localization sequence (NLS, purple) and a 240bp sequence encoding the VP16 activation domain was inserted into
the pUAST vector using the Asp718 and XbaI sites. The stop codon TGA is 10bp downstream of the insert, in the polylinker. dEcoRI
indicates a destroyed EcoRI site.
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5.1.2 Cloning of BrkVP16 
A fragment encoding the first 100 amino acids of Brinker, a nuclear localization signal (NLS) 
and the activation domain of the Herpes simplex virus protein VP16 was inserted into the 
pAc5.1/V5-HisB vector (Invitrogen) via its XbaI and Asp718 site for expression in S2 
Schneider cells. 
For generation of transgenic flies, the BrkDBD-NLS-VP16 construct was inserted into the 
expression vector pUAST (Brand and Perrimon, 1993). See Fig. 5.1 for detailed sequence 
information. 
5.1.3 P-element mediated transfomation 
Initial dad enhancer reporter genes and the UAS-BrkVP16 construct were transformed into 
Drosophila embryos by standard P element transfomation. 15µl of 0.4µg/µl plasmid with 
0.2µg/µl helper plasmid pπ25.7wc (Karess and Rubin, 1984) in 5mM KCl, 100µM NaxHxPO4 
pH6.8 were spun for 20min at 4°C at maximum speed in an refrigerated Eppendorf tabletop 
centrifuge to remove any particles. The supernatant was transferred into new tubes and kept 
on ice for direct use or stored at -20°C. Embryos from white-eyed yw flies were collected 
from grape juice plates, aligned on double-sided adhesive tape, dried with a cold-air hair dryer 
(Trisa Professional 1200), covered with Voltalef PCTFE oil (Atofina) and injected with the 
plasmid solution from the posterior end. 
Embryos were kept at 18°C for one to two days and then transferred to 25°C. Developing 
adult animals were crossed with yw flies and the off-spring screened for red-eyed w+ 
individuals carrying the transgene. Independent insertions were mapped and balanced using 
standard fly stocks. 
Figure 5.2  
Generation of transgenic flies using the attB/attP system. Embryos homozygous for the attP landing site on the third chromosome and the
ΦC31 integrase (driven by the vasa enhancer) on the fourth chromosome were injected with attBlacZ plasmids containing the enhancer
fragment of interest and a mini white gene. Adult animals developing from these embryos (G0), potentially chimeric with transformed 
germline cells, were crossed with y– w– flies. The offspring (F1) was then screened for individuals with red eyes. Red-eyed flies were isolated 
and crossed with flies carrying standard third chromosome balancers. 
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5.1.4 Transformation using the attB/attP system 
For generation of transgenic flies using the attB/attP system (Bischof et al., 2007), flies 
homozygous for the attP landing site on the third chromosome and the integrase on the fourth 
chromosome (strain internally named J5) were used. See Fig. 5.2 for detailed information. 
DNA and embryos were prepared as described in 5.1.3 (no helper plasmid was used). 
5.2 S2 reporter assay 
5.2.1 Maintenance and transfection of S2 cells 
S2 Schneider cells were grown at room temperature in Schneider’s Drosophila Medium 
(Gibco), supplemented with 10% Foetal Bovine Serum (Gibco), Glutamax (Gibco) and 
100U/ml penicillin, 100µg/ml streptomoycin (Gibco). When passaging the cells into new 
flasks, half of the old (conditioned) medium was transferred. For transfection, 600.000 cells 
were transferred into one well of a 12-well-plate. 200ng of total DNA was transfected using 
the Effectene Transfection Reagent (Qiagen): 150ng TkvQD, Mad, Medea (50ng each) and 
10ng luciferase encoding expression plasmids (pAc5.1/V5-HisB, Invitrogen) and 40ng of 
lacZ reporter gene (in px27). For BrkVP16, 50ng was applied. If not all effector plasmids 
were transfected, empty pAc5.1/V5-HisB vector was used to bring DNA amount to 200ng. 
5.2.2 Preparation and analysis of cell extracts 
After two days of growth, cells were harvested in 15ml Falcon tubes and spun down by 
centrifugation (700g, RT, 3min). The supernatant was removed and the cells resuspended in 
PBS and transferred to 1.5ml Eppendorf tubes. After repetition of the spinning and washing 
step, supernatant was removed and the cells resuspended in 70µl ice-cold cell lysis buffer. 
After incubation on ice for 10min, cells were centrifuged in a refrigerated Eppendorf tabletop 
centrifuge at maximum speed at 4°C for 15min. 10µl of the supernatant was transferred in one 
well of  a 96 multiwell plate. 200µl Z buffer was added and the OD change at 550nm was 
measured over 1 h at 37°C in a Thermomax microplate reader (Molecular Devices Corp) at 
37°C. For evaluation, the slope value was calculated by the associated software (Softmax 
PRO). 
To account for differences in cell growth and transfection efficiency, values for βgal activity 
were normalized by measuring the activity of the co-transfected luciferase. 350 µl luciferase 
reaction buffer was pipetted to 10µl cell extract. Light emission was initiated by addition of 
50µl luciferase injection mix and quantified using a Microlite TLX1 luminometer (Dynatech 
laboratories). All measurements were done at least in duplicate and standard deviation was 
calculated. 
5.2.3 Solutions 
Cell lysis buffer 1% Triton X-100 (Fluka) 
 25mM Gly-Gly (Sigma) pH 7.8 
 15mM MgSO4 
 4mM EGTA 
 1mM DTT 
 
Luciferase reaction buffer 25mM Gly-Gly (Sigma) pH 7.8 
 10mM MgSO4 
 2mM ATP (Sigma) 
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Luciferase injection mix 25mM Gly-Gly (Sigma) pH 7.8 
 0.2mM Luciferin (Sigma) 
 
Z buffer 100mM NaxHxPO4 pH 7.4 
 1mM MgCl2 
 0.314% Mercaptoethanol (Sigma) 
 0.25µg/µl CPRG 
5.3 Electrophoretic mobility shift assay 
5.3.1 Bacterially produced proteins 
Bacterially produced DNA binding domains of Mad, Medea and Brinker were provided by 
Georgios Pyrowolakis. Recombinant GST-MadMH1 and GST-MedMH1 proteins (amino 
acids 1-147 and 16-355, respectively, fused to the GST moiety in the plasmid pGEX4T.1 
(Pharmacia)) were expressed in E. coli BL21 cells, purified using Glutathione-Sepharose 
beads (Pharmacia) and stored at -80°C in 50mM KCl and 10% glycerol. 
BrkDBD comprises residues G43 to N101. The respective construct was subcloned from brk 
full-length cDNA into pET-22b(+) expression vectors expressed in E. coli BL21. The protein 
was purified as described by Cordier et al. (2006) and stored at a concentration of 1.5µg/µl in 
50mM Tris pH 8.0 and 100mM NaCl. 
5.3.2 Production of cell extracts 
For all experiments, S2 cell extracts were applied, except for the definition of the AE 
consensus sequence, where HEK293 cell lysates were used. Drosophila S2 cells were 
maintained as described in 5.2.1. Human HEK293 were cultured in DMEM + Glutamax 
(Gibco), supplemented with 10% Foetal Bovine Serum (Gibco), and 100U/ml penicillin, 
100µg/ml streptomoycin (Gibco) at 37° C in a humidified atmosphere containing 5% CO2. 
4mio S2 cells or 600’000 HEK293 cells were transferred into one well of a six-well plate and 
transfected with 400ng of total DNA, using the Effectene Transfection Reagent (Qiagen). 
100ng of TkvQD- and 150ng of both Mad- and Med-expression plasmids (pAc5.1/V5-HisB, 
Invitrogen, for S2 cells, pcDNA3.1, Invitrogen, for HEK293 cells) were applied. If not all 
plasmids were transfected, empty vector was used to bring total DNA amount to 400ng. 
After two days of growth, cells were harvested in 15ml Falcon tubes and spun down by 
centrifugation (700g, RT, 3min). The supernatant was removed and the cells resuspended in 
PBS and transferred to 1.5ml Eppendorf tubes. After repetition of the spinning and washing 
step, supernatant was removed and the cells resuspended in 70µl ice-cold lysis buffer and 
incubated on ice for 5min. Subsequently, cells were vortexed and snap-frozen in liquid 
nitrogen. This step was repeated at least two more times. Finally, cells were centrifuged in a 
refrigerated Eppendorf table top centrifuge at maximum speed at 4°C for 10min. The 
supernatant was transferred in new chilled tubes and either used directly in a mobility shift 
assay or snap-frozen and stored at -80°C. 
5.3.3 Preparation of radioactively labeled probe 
Double stranded probes with 5’-AATT overhangs were generated by incubating 10µl of 
100µM forward and 10µl of 100µM partially reverse complement oligonucleotides in 100µl 
annealing buffer for 10min at 75°C. The probe was then slowly cooled down to room 
temperature. For radioactive labeling, 1µl 10µM doublestranded probe was incubated at room 
temperature for 30min in 30µl Klenow buffer with 0.2mM dCTP, dTTP, dGTP, 2U Klenow 
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fragment (Roche) and 2µl of 0.5 to 0.8 MBq [α-32P]dATP. After deactivation of the enzyme 
at 72°C for 5min, non-integrated nucleotides were removed using illustra MicroSpin G-25 
Columns (GE Healthcare). Radioactivity was measured using a liquid scintillation analyzer 
(2000CA Tri-Carb, Packard). 
5.3.4 Electrophoretic mobility shift assay 
Binding reactions were carried out in 20µl Binding Buffer, containing 0.5µg Poly(dI-dC) (GE 
Healthcare) and 10.000cpm radioactively labeled probe. As a protein source, either 3 to 4µl of 
cell extracts, 0.8µg bacterially expressed Brinker-DBD, 1µg GST-MadMH1 or 0.4µg GST-
MedeaMH1 were used. For the Brinker/Smads competition assay, 8ng, 80ng and 0.8µg 
Brinker-DBD was used 
After incubation on ice for 30min, the complete reaction was loaded on a 4% non-denaturing 
polyacrylamide gel and run at 4°C in 0.5% TBE at 180mV. A single lane was loaded with a 
solution of bromphenol blue (BPB) indicator (Merck) to monitor the gel-run. When the 
indicator was as close as 4cm to the edge of the gel, the run was stopped and the gel 
transferred onto a Whatman 3M paper. After drying at 80°C using a vacuum pump, the blot 
was exposed to an X-ray film (Super RX, Fuji) between two signal-intensifying screens 
(Hyperscreen, Amersham Bioscience) at -80° for an appropriate amount of time (several 
hours to days). The films were developed using an automatic film processor (RG II, Fuji) and 
scanned with a transparency flatbed scanner (Epson Expression 1680 Pro). 
5.3.5 Solutions 
Lysis buffer: 1.2M KCl 
 40mM Tris pH 7.8 
 40% Glycerol 
 10mM NaF 
 2mM Na3VO4 
 2mM Na4PPi 
 1x Protease Inhibitor Mix (Roche) 
 
10x Annealing buffer: 100mM Tris pH 7.5 
 500mM NaCl 
 10mM EDTA 
 
2x Binding Buffer: 40mM HEPES pH 7.5 
 200mM KCl 
 2mM DTT 
 0.6% BSA (Fluka) 
 40% Glycerol 
 0.02% Nonidet P 40 (Fluka) 
 
10x Klenow buffer: 500mM Tris pH 7.5 
 100mM MgCl2 
 50mM DTT 
 
Polyacrylamide gel (4%): 4% 29:1 Acrylamide / Bis solution (Biorad) 
 0.5x TBE (AppliChem) 
 0.083% APS (AppliChem) 
 0.058% N,N,N’,N’-Tetramethyl-ethylene diamine (SERVA) 
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5.4 Co-precipitation of pSmad 
5.4.1 Procedure 
An aliquot of 50µl original Streptavidin Sepharose resuspension (GE Healthcare) was spun 
1min at 5000rpm in an Eppendorf tabletop centrifuge. Beads were washed three times in PBS 
to remove ethanol and spun for 1min at 5000rpm after each wash. After incubation for 30min 
at room temperature in 50µl blocking buffer, beads were washed three times with 500µl 
binding buffer. Finally, liquid was completely removed using an Eppendorf GELoader tip. 
The reaction solution containing HEK293 cell extracts (produced as described in 5.2.2) and 
biotinylated double stranded probe (annealed as described in 5.3.3) was applied. After 
incubation at 4°C for at least 2h, beads were washed three times with 500µl binding buffer. 
Liquid was completely removed using an Eppendorf GELoader tip and 25µl 2x Sample buffer 
was added. After boiling at 100°C for 4min, samples were stored at -20°C or loaded directly 
on a 10% denaturing polyacrylamide gel, prepared according to standard protocols (Sambrook 
and Russell, 2001) in a Mighty Small Gel Caster (Hoefer). After electrophoretic separation, 
using the Mighty Small II system and 30mA per gel (Amersham Biosciences), proteins were 
transferred onto a nitrocellulose membrane (Schleicher & Schuell) with a Mini Transblot Cell 
(Biorad) at 4°C and 100V for 1h. (Hoefer). After successful transfer, the nitrocellulose 
membrane was stained with Ponceau S (Serva) to visualize the protein bands. The membrane 
was rinsed with water and blocked in 5% milk powder (Migros) in PBST for 1h. 
Subsequently, the membrane was incubated over night at 4°C with the α-pSmad antibody (α-
pSmad1, 5, 8; Cell Signalling, 1:1000 in 5% milk powder in PBST), rinsed and washed three 
times with PBST for 10min and then incubated for 1h with the secondary HRP-conjugated α-
rabbit antibody (GE Healthcare, 1:1000 in 5% milk powder in PBST). After rinsing and 
washing with PBST, the bound antibodies were visualized using the ECL detection system 
(GE Healthcare). Chemiluminescence films (Amersham Hyperfilms, GE Healthcare) were 
exposed for various periods of time, depending on signal strength, developed using an 
automatic film processor (RG II, Fuji) and scanned with a transparency flatbed scanner 
(Epson Expression 1680 Pro). 
5.4.2 Solutions 
2x Binding Buffer 40mM HEPES pH 7.5 
 200mM KCl 
 2mM DTT 
 0.6% BSA (Fluka) 
 40% Glycerol 
 0.02% Nonidet P 40 (Fluka) 
 
Blocking buffer 50µl 2x Binding Buffer 
 20µl 0.5µg/µl dIdC (GE Healthcare) 
 20µl 0.5µg/µl herring DNA (Fluka) 
 10µl H2O 
 
Reaction solution 37µl 2x Binding Buffer 
 4µl 0.5µg/µl dIdC (GE Healthcare) 
 3µl biotinylated annealed oligo (1.2µg for 60bp dsDNA) 
 30µl cell lysate 
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2x Sample buffer 4% SDS 
 200mM DTT 
 120mM Tris pH 6.8 
 20% Glycerol 
 Bromphenol blue (Merck) 
5.5 Expression analysis in fly and fish 
5.5.1 Collection and fixation of Drosophila embryos 
5.5.1.1 Procedure 
Embryos were collected for about 12h at room temperature on grape juice plates and then 
dechorionized for 3min with 3.5% sodium hypochlorite solution. After rinsing with wash 
solution, embryos were transferred into a tube with 500µl n-heptane and 500µl embryo fix 
and rotated quickly for 20min. For devitellinisation, the aqueous phase was removed and 
replaced with 500µl methanol. Embryos were shaken vigorously or quickly vortexed, washed 
three times for 20min in methanol and finally stored in methanol at -20°C.  
5.5.1.2 Solutions 
Wash solution 120mM NaCl 
 0.03% Triton X-100 (Fluka) 
 
Embryo fix 2x PBS 
 9.6% Formaldehyde (Fluka) 
5.5.2 Whole mount Drosophila embryo in situ hybridization 
5.5.2.1 Procedure 
75µl of fixed embryos were transferred into a 1.5ml microfuge tube, rinsed once with 1ml 
PBST/methanol 1:1 and washed with PBST (0.1% Tween 20 (Fluka) in PBS) for 5min on a 
rotor. After fixation in 500µl 4% PFA (Paraformaldehyde, EM-grade, Fluka) in PBST for 
20min, embryos were rinsed twice with PBST and washed three times with PBST for 5min. 
Embryos were incubate for not more than 5min in 50µg/ml Proteinase K in PBST. Digest was 
ended by rinsing with 2mg/ml glycine solution and subsequent washing for 2min with glycine 
solution. After three times rinsing with PBST, embryos were fixed again in 500µl 4% PFA in 
PBST for 20min, rinsed twice with PBST and washed three times for 5min. 
Afterwards, embryos were washed 5min in PBST/HBS (1:1), then 5min in HBS. Then, 
embryos were prehybridized in 300µl prewarmed HBSR at 56°C for at least 1h. HBSR was 
removed except for a thin layer covering the embryos. After addition of 1µl of digoxigenin-
labeled RNA probe (dad probe provided by Anna Jazwinska, lacZ probe provided by 
Georgios Pyrowolakis), embryos were left over night at 56°C, slowly shaking. 
The next day, HBSR was removed. Embryos were rinsed three times with 500µl 56°C HBS 
and then washed three times with 1ml 56°C HBS for 20min. After washing with 1ml 56°C 
HBS/PBST (3:1), 1ml 56°C HBS/PBST (1:1) and 1ml room temperature HBS/PBST (1:3) for 
10min each, embryos were rinsed and washed twice with PBST for 5min. 
Embryos were incubated with AP-conjugated α-digoxigenin antibody (Roche, 1:2000) in 
Western Blocking Reagent (Roche, diluted in PBST) for 2h at RT or over night at 4°C. To 
identify homozygous mutant embryos, lacZ reporter expression of balancer chromosomes was 
detected by addition of an α-βgal antibody (Promega, 1:1000). After incubation, embryos 
were rinsed twice with PBST, washed three times for 20min in PBST, rinsed and washed 
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three times for 5min with 1ml freshly prepared AP buffer and incubated in 500µl staining 
solution per sample (6.6µl 50µg/µl NBT and 3.3µl 50µg/µl BCIP per 1ml AP buffer). The 
reaction was followed under the microscope using an aliquot of embryos and stopped by 
rinsing and washing with PBST for 10min. 
For double stainings, embryos were incubated with the secondary biotinylated α-mouse 
antibody (Vector laboratories, 1:500) in Western Blocking Reagent for 2h at RT or over night 
at 4°C and further processed as described in 5.5.3. 
Otherwise, embryos were dehydrated by subsequent washes in 40%, 70%, 96% and 100% 
ethanol, left over night at 4°C and mounted in 300µl mounting medium. After incubation over 
night, embryos were transferred to microscope slides.  
5.5.2.2 Solutions 
HBS (Hybr. sol.) 400ml Formamide 
 200ml 20x SSC (17.53% NaCl, 8.82% Sodium citrate) 
 40mg Heparin sodium salt (Fluka) 
 8ml 20% Tween 20 (Fluka) 
 H2O to 800ml  
 stored at -20°C 
 
HBSR (HBS+DNA) HBS 
 0.1 mg/ml sonicated salmon sperm DNA (MB-grade Roche) 
 stored at -20°C 
 
AP buffer 100mM NaCl 
 50mM MgCl2 
 100mM Tris pH 9.5 
 0.2% Tween 20 (Fluka) 
 
BCIP 50µg/µl 5-Bromo-4-chloro-1H-indol-3-yl phosphate · p-
toluidine (Bachem AG) in 100% dimethylformamide 
stored at -20°C 
Do not use DMF in polystyrene tubes! 
 
NBT 50µg/µl 4-Nitro blue tetrazolium chloride (Roche) in 70% 
dimethylformamide 
stored at -20°C 
Do not use DMF in polystyrene tubes! 
 
Mounting medium 80% Canada balsam (SERVA) 
 20% Methyl salicylate (Fluka) 
5.5.3 Whole mount Drosophila embryo antibody staining 
5.5.3.1 Procedure 
75µl of fixed embryos were transferred into a 1.5ml microcentrifuge tube, rinsed once with 
1ml PBST/methanol 1:1 and washed twice with PBST (0.1% Tween 20 (Fluka) in PBS) for 
5min on a rotor. After incubation in Western Blocking Reagent (Roche, diluted in PBST) for 
20min, embryos were incubated with the primary α-βgal antibody (Promega, 1:1000) in 
Western Blocking Reagent over night at 4°C or for 2h at room temperature. Afterwards, 
embryos were rinsed and washed three times with PBST for 10min. 
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For AP stainings, embryos were incubated with the secondary AP-conjugated α-mouse 
antibody (Boehringer Mannheim/abcam, 1:1000) in Western Blocking Reagent over night at 
4°C or for 2h at room temperature and then processed as described in 5.5.2. 
For HRP stainings, the Vectastain kit (Vector laboratories) was used. Embryos were 
incubated with the secondary biotinylated α-mouse antibody (Vector laboratories, 1:500) in 
Western Blocking Reagent for 2h at RT or over night at 4°C. Subsequently, embryos were 
rinsed with PBST and washed three times for 15min. According to the manufacturer’s 
protocol, embryos were then incubated in 1ml PBST, 16µl A and 16µl B for 30min (after 
preceding AB complex formation). Then, embryos were washed with three times with PBST 
for 10min and incubated in 500µl staining solution. The reaction was followed under the 
microscope using an aliquot of embryos and stopped by rinsing and washing with PBST for 
10min. Afterwards, embryos were dehydrated by subsequent washes in 40%, 70%, 96% and 
100% ethanol, left over night at 4°C and mounted in 300µl mounting medium. After 
incubation over night, embryos were transferred to microscope slides 
 
5.5.3.2 Solutions 
Staining solution 100µl 1M TrisHCl 
 10µl 25mg/ml Diaminobenzidine 
 0.4µl 30% H2O2 
  
Mounting medium 80% Canada balsam (SERVA) 
 20% Methyl salicylate (Fluka) 
5.5.4 XGal staining imaginal discs 
5.5.4.1 Procedure 
Third instar larvae were opened, inverted and transferred to a 24-well plate with PBS. After 
fixation for 15min in 1% Glutaraldehyde (Fluka) in PBS on ice, fixative was removed and 
larvae rinsed twice. Subsequently, 500µl XGal staining solution per well was added. Larvae 
were incubated at 37°C for 1h, rinsed twice with PBST (0.1% Tween 20 (Fluka) in PBS) and 
then dissected in PBS. Imaginal discs were transferred onto a microscope slide with 80% 
glycerol.  
5.5.4.2 Solutions 
XGal staining solution 960µl Buffer B 
 10µl 333mM K4[FeII(CN)6]xH2O 
 10µl 333mM K3[FeIII(CN)6] 
 5µl 10% Triton X-100 (Fluka) 
 16µl 5% XGal (AppliChem) in dimethylformamide 
 
Buffer B 500µl 200mM NaPi pH 7.2 
 300µl 5M NaCl 
 10µl 1M MgCl2 
 H2O to 10ml 
5.5.5 XGal staining zebrafish embryos 
5.5.5.1 Procedure 
5xAE, 5xSE reporter constructs and the control vector were injected into one- and two-cell 
stage zebrafish embryos in a concentration of 10 to 40ng/µl. To inhibit BMP-mediated Smad 
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phosphorylation, 10µM Dorsomorphin (Sigma) was applied to the medium as soon as 
embryos reached the 1000-cell stage. Embryos were allowed to develop at 28.5°C until 
approx. 60% epiboly and then fixed in fish fix solution for 8min at room temperature. After 
washing four times in washing solution, embryos were incubated overnight at 37°C in XGal 
ZF staining solution. Staining was stopped by rinsing with PBST (0.1% Tween 20 (Fluka) in 
PBS). 
 
5.5.5.2 Solutions 
Fish fix solution PBS 
 2mM MgCl2 
 12% Glutaraldehyde 
 
Washing solution PBS 
 2mM MgCl2 
 0.3% Triton X-100 (Fluka) 
 
XGal ZF staining solution 914µl Buffer B 
 30µl 333mM K4[FeII(CN)6]xH2O 
 30µl 333mM K3[FeIII(CN)6] 
 5µl 10% Triton X-100 (Fluka) 
 16µl 5% XGal (AppliChem) in dimethylformamide 
 
Buffer B 500µl 200mM NaPi pH 7.2 
 300µl 5M NaCl 
 10µl 1M MgCl2 
 H2O to 10ml 
 
5.5.6 Documentation 
Stainings of Drosophila embryos and imaginal discs were documented with a Colorview II 
digital camera (Soft Imaging System) in combination with an Axiophot microscope (Zeiss). 
Images were processed using the analySIS software (Soft Imaging System). 
Stainings of zebrafish embryos were documented with a DFC420 C digital camera (Leica), 
connected to a MZ FLIII stereomicroscope (Leica). Images were processed using the Leica 
Application suite. 
5.6 Bioinformatic tools 
Drosophila sequence informations and related gene maps were retrieved from Flybase 
(http://www.flybase.org) and the VISTA Genome Browser (Frazer et al., 2004; Mayor et al., 
2000), available at http://genome.lbl.gov/vista/. The latter was also used for alignments of 
genomic sequences from D. melanogaster and other Drosophila species. 
The entire Drosophila genome was screened for putative AEs using the Flyenhancer search 
tool (Markstein et al., 2002), available at http://www.flyenhancer.org. 
Positions of putative Smad and Brinker binding sites within the dad enhancer were visualized 
using the program dna-pattern at http://rsat.ulb.ac.be/rsat/ (van Helden et al., 2000). 
The intensity of the mobility shift bands for defining the Brinker binding consensus sequence 
was measured using the software ImageJ (Abramoff et al., 2004), available at 
http://rsbweb.nih.gov/ij/. 
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5.7 Fly strains 
w;; prd-Gal4 / TM3 GAL4 gene driven by regulatory elements from the paired 
locus. Affolter lab stock #302. 
 
UAS brk brinker gene driven by UAS elements. Affolter lab stock #251. 
 
UAS brkVP16 Gene encoding a recombinant BrkDBD-VP16 protein, driven 
by UAS elements. Strain 13, on second chromosome. 
 
yw brk / FM7c ftz-lacZ brinker mutant, balanced over “blue” balancer. Affolter lab 
stock #201. 
 
shnTD5 / CyO wg-lacZ schnurri mutant, balanced over “blue” balancer. Derived from 
Affolter lab stock #278. 
 
tkv / CyO wg-lacZ  thickveins mutant, balanced over “blue” balancer. Affolter lab 
stock #318. 
 
UAS tkvQD Gene encoding the constitutively active receptor Thickveins, 
driven by UAS elements. Affolter lab stock #231. 
 
UAS shnVP16 Gene encoding a recombinant Shn-VP16 protein, driven by 
UAS elements. Obtained from Britta Hartmann (#132). 
 
p1883 / TM3 dad lacZ enhancer trap (Tsuneizumi et al., 1997). 
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6 Results 
6.1 Analysis of dad expression and regulation 
6.1.1 dad expression follows dpp expression 
In contrast to the expression pattern of dpp, the expression pattern of dad in the Drosophila 
embryo has been poorly described. To compare the expression domains of dpp and its 
potentially direct target gene dad, we performed in situ hybridizations. Since Dpp plays an 
important role in the dorsal-ventral axis formation, the dpp transcript is localized dorsally 
already in the very early embryo (Fig. 6.1A). During the process of germband extension, the 
dorsal expression refines into two clearly distinct segmented ectodermal stripes (B, C). Later 
on (D), dpp is also expressed in the visceral mesoderm of parasegment 7, in the ectoderm of 
foregut and hindgut as well as in anterior structures (Panganiban et al., 1990). 
Unlike dpp, dad transcripts are not localized dorsally in the young cellularized embryo but 
either absent or uniformly and weakly distributed (E). Only at about stage 6 to 7, dad 
expression becomes visible (F). After undergoing a refinement similar to that of dpp, dad 
expression follows the expression of dpp precisely and in every single aspect. Since Dpp acts 
extracellularly as a morphogen, the expression domain of dad is broader and includes also 
cells neighboring dpp expressing cells. This is also evident in the larval wing imaginal disc 
(Fig. 6.1), where dad expression follows dpp expression (both visualized using lacZ reporter 
lines) tightly along the anterior-posterior border. The same holds true for the expression of 
dad in leg and haltere discs. 
Figure 6.1 
Expression of dpp and dad.  The dad
expression (A to D) follows dpp expression (E 
to H) faithfully in the embryo after the end of 
germband extension (C, G) as well as in the 
larval wing imaginal disc (I, J). Embryonic 
expression was detected using in situ
hybridization, discs were stained with XGal.  
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6.1.2 dad expression is regulated by the Dpp pathway and Brinker  
Genes that are activated upon Dpp signalling fall into one of three different classes: genes that 
are directly activated by Dpp, genes that are directly activated by Dpp and at the same time 
repressed by the default repressor Brinker, and finally genes that are only repressed by 
Brinker and indirectly activated via Dpp-induced repression of the brinker gene. To determine 
the class the dad gene falls into, dad expression was analysed in different mutant backgrounds 
(Fig. 6.2). dad expression is completely abolished in thickveins and schnurri mutant embryos 
and expands widely in a brinker mutant background. Furthermore, ectopic expression of 
brinker under the control of a paired enhancer, using the UAS-GAL4 system (Brand and 
Perrimon, 1993), leads to strong local repression of dad. These observations suggest that dad 
is a brinker target. What remained unanswered was, whether there is also a direct Dpp input 
on dad. To address this question, we ectopically expressed the transgene tkvQD, which encodes 
the constitutively active form of the Dpp receptor Thickveins, and found that it led to clear 
upregulation of dad. Importantly, this was also the case in a brinker mutant background, 
indicating that this upregulation is independent of Brinker and suggesting that dad is 
regulated by both Dpp signalling and Brinker. 
Figure 6.2 
Genetic regulation of the dad gene. All images 
show dad in situ hybridizations in the wild type 
(A) and various genetic backgrounds (B to G). 
dad is not expressed in thickveins and schnurri
mutants (B, C) and expands widely in brinker
mutants (D). Expression of UAS-brinker by 
paired-GAL4 leads to ectopic repression (E). 
Expression of the constitutively active Dpp 
receptor thickveins induces ectopic activation of 
dad in a wild type (F) and brinker mutant
background (G), indicating a Brinker-
independent input on dad.  
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6.2 Identification of a minimal dad enhancer 
6.2.1 A lacZ reporter driven by the second dad intron resembles endogenous 
dad expression  
After having ensured that the dad gene receives an activating Dpp input, we analysed the dad 
genomic region in order to identify potential cis-regulatory elements. The dad gene is situated 
on the right arm of the third chromosome and stretches over 16kb (see Fig. 6.3). It contains 
seven introns, the biggest of them harboring the predicted gene CG31263 (which was, 
however, excluded from the newest Dmel genome release). Since cis-regulatory elements tend 
to be conserved during evolution, we initially screened the dad genomic region for stretches 
highly invariant among far related Drosophila species (see introduction) using the VISTA 
genome browser (Frazer et al., 2004; Mayor et al., 2000). At the same time we created 
different lacZ reporter constructs to identify the dad enhancer(s) and generated transgenic 
flies carrying these reporters. Whereas the construct Dad1+2 was never successfully cloned, 
the construct Dad3 (resembling the first intron) did not drive any lacZ expression in the 
embryo and larval imaginal discs. Dad4 (resembling the second intron) however was able to 
induce expression indistinguishably from the endogenous dad expression in embryonic as 
well as larval tissues (Figures 6.4 and 6.7). 
Figure 6.4 
Expression of the Dad4 reporter construct. The 
expression of lacZ driven by the Dad4 fragment  (E to 
H) recapitulates the endogenous dad expression (A to D) 
precisely. All images in situ hybridization. 
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Figure 6.3 
Genomic locus of the dad gene with initially planned reporter constructs. The dad gene is located on the right arm of the third 
chromosome and stretches over several exons. Three reporter constructs were designed, covering the pre-transcription start region, the first 
and the second intron. 
12’883’00012’878’000Chromosome 3R
CG5208 Dad CG31263 CG3983
12’893’00012’888’000
lacZ
lacZ
lacZ
Dad1+2
Dad3
Dad4
Results 
 
 
 
38
6.2.2 The minimal enhancer Dad13 contains putative Smad and Brinker 
binding sites and is highly conserved 
 
 
Figure 6.5 
Detailed view and conservation of the minimal enhancer Dad13 and subconstructs. Degree of conservation visualized using the VISTA 
genome browser. Regions highly conserved in D. pseudoobscura and D. virilis are colored in red. Two clusters of putative transcription 
factor binding sites can be found, that are highly conserved in other Drosophila species (marked with asterisks) Color intensity of the 
enhancer constructs indicates the strength of expression. Constructs depicted in grey did not show any staining at all. Dad10+10 stands for a 
dimerized Dad10 construct. Clearly, expression levels are correlated with the size of the enhancer fragments. Sequence analysis reveals that 
several Mad and Brk sites are conserved among different species and overlap due to the similarity of their consensus sequences.  
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Our next aim was to successively reduce the size of the enhancer construct in order to identify 
the minimal enhancer. We ended up with a 520bp construct, Dad13. Dad13 drives expression 
of a lacZ reporter in an identical pattern to that of Dad4 (Fig. 6.7) and consists of two 
conserved regions of about 150bp each, separated by a poorly conserved DNA stretch (Fig. 
6.5). Since genetic data indicated a regulation of dad by both Brinker and Dpp, we screened 
Dad13 for potential Brinker and Smad binding sites. For Brinker, we used the experimentally 
derived consensus sequence GGCGYY (Sivasankaran et al., 2000; Zhang et al., 2001). To 
track down Smad binding sites, we used both the simple Smad-binding element (SBE) AGAC 
(Shi et al., 1998; Zawel et al., 1998) as well as the sequence GRCGNC, which has been 
shown to recruit Drosophila Mad proteins (Gao et al., 2005; Pyrowolakis et al., 2004). Most 
of the sites found fall into the two highly conserved clusters. We also noticed that all highly 
conserved potential Brinker binding sites completely overlap with Mad binding sites, 
suggesting a possible competition as it has been reported for other Dpp responsive enhancers 
(Kirkpatrick et al., 2001; Rushlow et al., 2001). Additionally, a tandem SBE repeat was 
identified. Despite extensive searches, no transcription factor binding sites could be reliably 
assigned to a perfectly conserved 50bp region at the 5’ end of Dad13. 
To determine whether the high degree of conservation was reflected in similar expression 
patterns, we cloned the corresponding genomic regions Dad13V and Dad13PO from D. virilis 
and D. pseudoobscura - two species which diverged from D. melanogaster as long as 40 and 
25 million years ago respectively. The lacZ reporter plasmids containing these enhancers 
were then transformed into D. melanogaster embryos. The resulting expression patterns in the 
embryo and larval discs highly resembled that of Dad13 (Fig. 6.6), suggesting an important 
function of the conserved elements. 
 
Figure 6.6 
Expression of the corresponding Dad13 constructs from other 
Drosophila species. The homologous genomic regions of Dad13 from 
D. pseudoobscura and D. virilis were cloned and transformed as lacZ
reporter constructs into D. melanogaster. Expression patterns were 
very alike in the embryo as well as in larval imaginal discs (in situ
hybridization and Xgal staining respectively). 
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6.2.3 Trimming of Dad13 leads to loss of activity 
Further attempts to significantly reduce the size of the Dad13 enhancer (Fig. 6.7) resulted in a 
constant decrease of expression strength, but never in a severe change in domains or width of 
expression (see Fig. 6.7). This pointed at a modular, somewhat redundant architecture of the 
enhancer with multiple sites of transcriptional input. This theory was strengthened by the fact 
that dimerization of otherwise inactive elements (as Dad10+10, Fig. 6.5) led again to an 
increase in expression. The fact that repressive and activating sequences could not be 
separated by simple trimming furthermore emphasized a potential competition of activators 
and repressors on the same sites. In general, loss of expression strength was less dramatic in 
the embryo than in the wing imaginal disc. Dad15 for example did not show any staining in 
the wing disc (Fig. 6.7), but was still inducing low expression levels in the embryo (data not 
shown). 
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Figure 6.7 
Decrease of expression with enhancer size. Reducing the size of the dad enhancer leads to a reduction in lacZ expression levels. The 
respective constructs are depicted in Fig. 6.5, Dad9+10 is a fusion construct of Dad9 and Dad10. While the strength of expression decreases, 
the expression domains remain unchanged. This indicates overlapping or closely neighbored repressor and activator binding sites. Color bars
at the figure bottom indicate the expression strength in the imaginal discs. All images show XGal stainings. 
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6.2.4 The minimal enhancer is regulated by Dpp and Brinker in vivo and in cell 
culture 
To decipher the transcriptional regulators responsible for activity of the identified dad 
enhancer and to test whether they are the same as for dad, we analysed its activity in mutant 
backgrounds and compared it to the expression patterns of dpp and brinker. As expected from 
an enhancer repressed by Brinker, the expression domains of brinker and dad13 (a lacZ 
reporter gene driven by the minimal enhancer Dad13) are mutually exclusive in the wing 
imaginal disc (Fig. 6.8). Furthermore, dad13 is derepressed in clones homozygous mutant for 
brinker. The expression pattern of dad13 closely reflects the Dpp activity domain and 
includes and surrounds the dpp expressing cells along the anterior-posterior border (Fig. 6.8). 
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Figure 6.8 
Regulation of the minimal enhancer.
The expression of dad13, a lacZ reporter 
gene driven by Dad13, was analysed in 
the wing imaginal disc. The expression 
patterns of brinker and dad13 are 
complementary (A). Furthermore, the 
expression domain of dad13 includes 
and flanks the expression domain of dpp
(B). Clones mutant for brinker
ectopically upregulate dad13 (C), 
whereas cells mutant for mad do not 
express dad13 (D). The clonal 
expression of tkvQD, which encodes the 
constitutively active Dpp receptor, leads 
to strong local induction of dad13. 
Mutant clones are indicated by loss of a 
GFP (C, D) or CD2 (E) marker (arrows 
show examples). Expression of brinker
was visualized by a GFP reporter gene 
driven by the brinker enhancer. dpp 
expressing cells were marked by the 
expression of dpp-Gal4 and UAS-GFP. 
The Expression of dad13 was detected 
using an anti-β-galactosidase antibody. 
All images were kindly provided by 
Enrica Charbonnier, University of 
Freiburg. 
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Cells that lack Mad protein do not express dad13, whereas clones expressing a transgene 
encoding the constitutively active Dpp receptor TkvQD strongly upregulate dad13. The same 
response to ectopic activation of the Dpp pathway can be seen in the embryo. A lacZ reporter 
gene driven by Dad4 is upregulated upon striped expression of tkvQD (Fig. 6.9). Furthermore, 
ectopic expression of a recombinant BrkVP16 protein (where the repression domain of 
Brinker was swapped with the strong activation domain of the Herpes simplex protein VP16) 
leads to strong induction of a Dad13 lacZ reporter. This indicates a direct involvement of 
Brinker in the regulation of dad. 
The use of cell culture experiments allows for fast and comparative testing of different 
shortened or mutated reporter constructs and various effector proteins. Although it does not 
replace the analysis of transgenic flies, it offers a convenient possibility to track down 
transcription factor binding sites. 
For the in vitro analysis of Dad13, S2 cells were transfected with the respective reporter 
plasmid and expression levels were determined by β-galactosidase activity. Basal expression 
Figure 6.9 
Regulation of the minimal enhancer. Expression of Brinker under the control of the paired enhancer (using the UAS-Gal4 system) leads 
to ectopic repression of the lacZ reporter gene, whereas the constitutively active Dpp receptor TkvQD leads to activation. Expression of the 
strong activator BrkVP16, where the Brinker repression domain was exchanged with an activating domain, results in ectopic activation of 
the reporter. All images show in situ hybridization, except α−βgal staining for dad13 prd>brkvp16. 
dad13 dad13 prd>brkvp16
dad4 prd>brk dad4 prd>tkvQD
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Figure 6.10 
Activity of the Dad13 enhancer in S2 cell culture. S2 cells were transfected with either a Dad13 lacZ vector, or an empty lacZ control 
vector and various combinations of plasmids encoding TkvQD, Mad and Medea. Results were normalized against levels of co-transfected 
luciferase. Right panel shows the same data normalized additionally against Dad13. Already Dad13 alone shows an activity seven-fold 
higher than the empty vector. Activation of the Dpp pathway increases this activity further drastically. 
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levels of a lacZ reporter driven by Dad13 were already more than seven-fold higher than that 
of a control plasmid. Co-transfection of plasmids coding for Mad, Medea and TkvQD further 
increased expression levels dramatically (Fig. 6.10). Comparative studies of the different 
enhancer constructs confirmed the results obtained from the in vivo expression analysis. 
Reduction in size leads to a decrease of enhancer activity (Fig. 6.11, compare to Fig. 6.7), 
including both basal activity and activity upon co-transfection of Mad, Medea and TkvQD. 
Expression of BrkVP16 results in strong activation of Dad13 and weaker activation of its 
subfragments Dad9 to Dad12 (Fig. 6.11). Strongest (relative) upregulation can be seen for the 
fragments Dad10, Dad11 and Dad12, which include a putative Brinker binding site. 
 
Figure 6.11 
Comparison of different enhancer constructs and effect of BrkVP16 expression. (Upper panel) Bars indicate relative levels of activity 
without (orange) and with (blue) co-transfection of plasmids encoding Mad, Medea and TkvQD, normalized against luciferase expression and 
activity of the empty lacZ vector px27. Activity decreases with the size of the enhancer fragments. (Lower panel) BrkVP16 is able to
strongly activate Dad13 and also smaller enhancer constructs, which is consistent with the localization of the putative Brinker binding sites.
Values were normalized against luciferase expression and activity of the empty vector px27. 
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6.3 Dissection of the minimal enhancer by biochemical analyses 
6.3.1 Mad/Medea and Brinker DNA binding domains bind to the dad enhancer 
 
After having found several potential sites for active Smad and repressive Brinker input by in 
silico analysis and cell culture experiments, we attempted to clearly identify the sites which 
bind transcription factors and submitted the respective DNA sequences to electrophoretic 
mobility shift assays (EMSA). We subdivided Dad13 into several oligonucleotides of 40 to 
70bp length, namely oligos S1 to S7 (Fig. 6.12), and tested purified DNA binding domains of 
Mad, Medea and Brinker for binding. All fragments containing putative Brinker binding sites 
were able to interact with the Brinker protein. Mad and Medea, however, were significantly 
recruited only to S2 (containing the 2xSBE), S3 and S7, that both contained clusters of 
potential Mad sites (Fig. 6.12). Longer exposure revealed weak binding of Mad also to S4 
(not shown, compare Fig. 6.13). 
Figure 6.12 
Binding of Smad and Brinker DNA binding domains to the dad enhancer. Seven different subconstructs (S1 to S7) were designed to 
decipher the sites of transcriptional regulation. The bacterially expressed DNA binding domain of Brinker efficiently bound to three
subfragments (green arrows). Binding of the Mad/Medea DNA binding domains could be observed for the oligos S2, S3, S7 and surprisingly 
only weakly for S4 after long exposure (Mad only). For detailed sequence information see figure 6.5. 
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To examine whether the design of S4 and its lack of flanking sequences was the reason for 
weak Mad binding, we tested the additional construct S4’, that was centered on the 
Mad/Brinker site (Fig. 6.13). This experiment confirmed the initial results. S4’ behaved 
exactly like S4, showing only very limited Mad binding. Since S3 contained two potential 
Brinker binding sites, we constructed another oligonucleotide (S3’) that lacked the first 
Mad/Brinker site. S3’ was not able to recruit Brinker and thus revealed that the missing site 
was the sole Brinker site within S3 and a major Mad site. Consequently, we mutated all 
Mad/Brinker sites by changing the core nucleotides from GRCGCC to GRATCC and tested 
for protein binding. The results showed that the sites 1, 4 and 7 were the only relevant Brinker 
binding sites (Fig. 6.14), whereas sites 1 and 7 were the strongest Mad/Medea sites (compare 
Fig. 6.15). 
 
 
 
Figure 6.13 
Retesting of binding sites in S3 and S4. To ensure that the binding behavior was not due to the design of the fragments, the shifted 
constructs S3’ and S4’ were also tested for Mad, Medea and Brinker binding. S3’ lacks one putative Brinker binding site included in S3 and
was not able to bind Brinker anymore. S4’ efficiently bound Brinker , but only weakly Mad, as already seen for S4 (see Fig. 6.11). 
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Figure 6.14 
Identification of Brinker and Smads sites. All putative Brinker binding sites were mutated by exchanging the two core nucleotides from
CG to AT and tested for Smad and Brinker binding. This led to the identification of three (palindromic) Brinker binding sites (1, 4 and 7). 
Mad and Medea bind more promiscuously, but mainly to two of these three Brinker sites (1 and 7). 
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Figure 6.15 
Summary of the mobility shift experiments with DNA binding domains. The color intensity resembles binding efficiency. Brinker binds 
to three sites within the Dad13 minimal enhancer, all of them perfectly palindromic. Mad binds strongly to two of these sites and weakly to 
other putative binding sites. The same holds true for Medea, however Medea also strongly binds to S2, which is very likely due to the tandem 
Smad binding element found there. This construct also displayed weak Mad binding. 
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6.3.2 Mad/Medea and Brinker compete for binding sites 
Due to the overlap of Brinker and Mad sites, we were tempted to speculate that these two 
transcription factors compete for binding. To test this hypothesis, a competitive assay was 
performed using S3, invariant amounts of Mad/Medea DNA binding domains and increasing 
amounts of Brinker DNA binding domain. Indeed, Brinker is able to compete away Mad and 
Medea (Fig. 6.16), which indicates a regulatory mechanism based on competition for the dad 
enhancer. 
  
Figure 6.16 
Smads and Brinker compete for the same binding sites. S3 was tested for competitive binding of Brinker and Mad/Medea. For this
purpose, increasing amounts of Brinker DNA binding domain were incubated with constant amounts of S3 and either Mad and Medea DNA 
binding domains. The binding of both Mad and Medea is clearly reduced in the presence of Brinker. 
0 200 400
S3
Consensus binding sites
Medea Mad Mad/Brinker
free probe
Brinker
Mad
Medea
Medea-MH1Mad-MH1
Brinker-DBD
13h
Results 
 
 
 
48
6.3.3 Binding of Mad/Medea and Brinker to Ubx and zen enhancer 
Competition of Brinker and Smads at the same binding sites has been previously 
demonstrated in detail for two enhancers: the Ubx midgut enhancer (Kirkpatrick et al., 2001) 
and the zen enhancer (Rushlow et al., 2001). In both studies recombinant tagged proteins 
were used for supershift assays. Since the sequences used by Rushlow and co-workers do not 
contain any GRCGNC motif (Fig. 6.17) but are reported to bind Mad, we tried to reproduce 
these results. At the same time we intended to redo the binding experiments from Kirkpatrick 
and co-workers. To see whether we were able to correctly predict the Brinker/Mad binding 
sites, we also introduced different mutations. 
The Dpp response element in the Ubx enhancer contains three potential Brinker sites; one of it 
fulfills also the Mad site consensus sequence GRCGNC (Fig. 6.18). No palindromic 
GGCGCC site can be found. Only mutagenesis of all three sites completely disrupts Brinker 
binding (Fig. 6.19). Compared to the dad enhancer, Mad and Medea bind only weakly to this 
enhancer (note the exposure time of one week). 
Figure 6.17 
Sequence of the two zen enhancer fragments tested for Brinker and Smad binding. Sequence from the zen enhancer, which was located 
within 1.6kb upstream of transcription start (Doyle et al., 1989). M6, M7, B4 and B5 were identified as Mad (M6, M7) and Brinker (B4, B5)
binding sites by Rushlow et al. (2001). The oligonucleotides B4M6 and B5M7 were reported to bind Mad and Brinker competitively in
mobility shift assays. B4M6 contains a putative Smad binding element, B5M7 a putative Brinker binding site. 
ZenB4M6 CTGGCGAGACTCCGGCTCTTGCGGCCCAG
ZenB5M7 TCTCTCACGCAACGCCAGATCCTGGCAGGA
Figure 6.18 
Sequence of the Dpp response element identified in the Ubx enhancer. Fragments D I and D II refer to nomenclature in the original 
documentation of the Ubx midgut enhancer  (Thuringer et al., 1993). Kirkpatrick et al. (2001) tested the Dpp response element in mobility 
shift assays for competitive binding of Brinker and Smads. In our attempts to reproduce these results, we additionally examined mutations
affecting the putative Mad (red box) and Brinker (green box) binding sites. 
Ubx Dpp RE GGACTGGCGTCAGCGCCGGCGCTTCCAG
m1 -------at-------------------
m2 -------------at-------------
m3 -------------------at-------
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The two sequences from the zen enhancer contain no putative Mad binding sites. ZenB4M6 
only carries a Smad-binding element and ZenB5M7 a possible Brinker binding site. Figure 
6.19 shows that Brinker binds extremely poorly to the two oligonucleotides. No Mad binding 
could be visualized, only Medea bound to ZenB4M6. This is in accordance with our 
expectations but in sharp contrast with the results published by Rushlow and co-workers 
(Rushlow et al., 2001). 
6.3.4 Converting Mad/Brinker sites into exclusive Mad sites 
All Brinker binding sites in the minimal dad enhancer are also putative Mad binding sites. 
Our mutagenesis experiments revealed that only two of them bind Mad strongly in vitro 
(compare Figures 6.14 and 6.15). Since Mad and Brinker bind to very similar, but not 
completely overlapping consensus sequences, it was tempting to test whether it was possible 
to convert a Brinker/Mad site into an exclusive Mad site. 
 
6.3.4.1 Definition of the Brinker site 
In an initial experiment we attempted to better characterize the published Brinker binding site 
(T)GGCGYY  (Sivasankaran et al., 2000; Zhang et al., 2001). We chose to perform a 
competitive shift assay using the perfect palindromic site TGGCGCCA and mutant 
oligonucleotides as “cold” competitors (Fig. 6.20). The intensity of the bands was measured 
using the software ImageJ (Abramoff et al., 2004) and the ratio of bound to unbound DNA 
was calculated. 
Figure 6.19 
Brinker/Smad binding to the Ubx and zen enhancer. Brinker binds strongly and multiply to the Ubx enhancer. Testing of the different 
mutated versions of the enhancer construct revealed that Brinker binding is completely abolished only by a triple mutation. Mad and Medea 
seem to interact only weakly, the result of the mutant constructs is not conclusive and implies a binding restricted not only to a single site.
Binding of Brinker to the zen enhancer constructs is poor. No Mad binding could be detected, only Medea in the case of B4M6. 
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The palindromic sequence TGGCGCCA, which can be found in two of three Brinker binding 
sites within the dad minimal enhancer, showed the highest binding efficiency. Oligo S7 from 
the dad enhancer that contains a perfect Brinker binding site showed a comparable binding 
efficiency. Mutations within the invariant region of the consensus sequence strongly reduced 
the binding efficiency. Interestingly, mutating the flanking nucleotides T and A (No 2 in Fig. 
6.20) led to a strong reduction in binding, confirming the findings of Zhang and co-workers 
who published the consensus sequence TGGCGYY with a 5’ T (Zhang et al., 2001). 
6.3.4.2 Mutation of the binding sites 
To convert the Brinker/Mad sites to exclusive Mad sites, we chose the constructs S3 and S4 
and mutated the sequence GGCGCC to GaCGtC. This new sequence would still fulfill the 
Mad consensus sequence GRCGNC, but not the Brinker consensus sequence GGCGYY 
anymore. When subjected to a shift assay, the mutant oligonucleotides indeed did not recruit 
Brinker anymore, but were still capable of binding to Mad and Medea (Fig. 6.21)  
Figure 6.20 
Quantification of Brinker binding. The double-stranded oligonucleotide aattCTACATGGCGCCAGTGATaatt was used in a competitive 
shift assay with increasing amounts of unlabelled competitors and constant amounts of Brinker DNA binding domain. For evaluation, the
ratio of 16.6 of cold to hot competitor was chosen. The intensity of the shifted and non-shifted bands was measured. Highest ratios were 
determined for the perfectly palindromic sequence (1) and two variants (10, 11). Oligo S7, containing one putative Brinker site from Dad13,
showed comparable binding. 
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6.3.5 A complex of full length Mad/Medea proteins is recruited onto the 
enhancer 
Binding studies of BMP responsive enhancers and Smad proteins are in most cases not 
performed with full length proteins but with bacterially expressed DNA binding MH1 
domains. The MH1 domain of Smads binds to a small so-called Smad binding element (SBE), 
GTCT. However, the MH1 domain interacts mainly with the two G residues (one on the other 
strand) and allows some flexibility for the other bases (Shi et al., 1998; Zawel et al., 1998). 
The consequence is a quite versatile binding behavior which does not necessarily allow 
conclusions for the in vivo situation, where Smad proteins bind in a cooperative complex with 
other factors. Furthermore, full length proteins demonstrate an autoinhibitory function, thus 
restricting the binding activity of the MH1 domain by the MH2 domain (Hata et al., 1997). 
Only few enhancers so far have been shown to bind a complex of full length Mad and Medea, 
namely the brinker, bam and gooseberry enhancers (Gao et al., 2005; Müller et al., 2003; 
Pyrowolakis et al., 2004). To test whether also the dad enhancer harbors such high affinity 
sites, we transfected tissue culture cells with plasmids encoding Mad, Medea and the 
constitutively active Type I receptor ThickveinsQD (TkvQD) and used the cell extracts for 
mobility shift experiments. We found that S3 and S7 (containing the two major Mad sites) 
were able to recruit a complex of Mad and Medea (Fig. 6.22). In the case of S3, this 
interaction was only visible upon co-transfection of all three proteins (Fig. 6.23). Mad as well 
as Medea alone was not able to bind, independent of the co-transfection of TkvQD. 
Figure 6.21 
Brinker/Mad sites can be converted into sole Mad sites. Mutation of the Brinker binding site GGCGCC to GACGTC abolishes Brinker 
binding completely for S3 and S4. Mad and Medea binding behavior is unaltered. This result is confirmed in a competitive assay where
increasing amounts of unlabelled S3 wild type oligonucleotide can compete away Brinker, whereas the mutated form cannot. 
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Figure 6.22 
Mad/Medea complex formation. 
The constructs S1 to S7 from the 
Dad13 minimal enhancer were 
subjected to a binding assay with 
extracts from either S2 cells 
transfected with Mad/Medea/ 
TkvQD or control cells. Formation 
of a specific complex was observed 
for S3 and S7 (red arrows). 
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Figure 6.23 
Requirements for Mad/Medea 
complex formation. Different 
combinations of transfected proteins
were tested for complex formation.
Only when Mad, Medea and TkvQD
were expressed within the same
cells, a mobility shift was observed
for the respective lysates. Addition
of separately transfected Medea
lysates to Mad/TkvQD lysates, for 
example, was not sufficient for
complex formation.  
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6.3.6 Identification of the minimal element that is able to recruit Mad/Medea 
After having identified two Dad13 subconstructs carrying binding sites for a Mad/Medea 
complex, we sought to further define the sequences responsible for Smad recruiting. For that 
purpose we focused on S3. In a first attempt we tested the constructs used in Fig. 6.14, where 
two Mad/Brinker sites were destroyed. As can be seen in Fig. 6.24, mutation of the first Mad 
site is sufficient to completely abolish Mad/Medea complex formation, whereas destruction of 
the second putative Mad site does not influence Smad binding. In the next steps we 
successively cropped S3 while checking whether Mad and Medea were still able to bind. 
In the process of dissection we first removed nucleotides adjacent to the putative binding sites 
(compare sequences in Fig. 6.25). The resulting constructs were still able to recruit Smad 
complexes, also after removal of the 3’ most putative Mad site (S3xxs). Further analysis 
revealed a minimal fragment still suitable for complex formation: S3xxs6. Smaller constructs 
still showed weak binding. It remains possible that they were simply too small for effective 
interactions and that the composition of the flanking nucleotides was of no importance. Later 
experiments confirmed this theory. 
An alternative subconstruct of S3 excluding the 5’ most Brinker site (S3xxsb) did not show 
any Mad/Medea binding (Fig. 6.25). 
Figure 6.24 
Detection of the Mad/Medea binding sites. The same 
oligonucleotides already used in Fig. 6.13 with mutations in the 
two putative Brinker sites were incubated with extracts from 
Mad/Medea/TkvQD-transfected cells. Mutation of the first
Mad/Brinker site completely abrogated complex formation 
whereas mutation of the second site did not have any effect.
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Since S7 also showed Mad/Medea binding (though weaker than S3), we also tested two 
subconstructs, S7xxs and S7xxsb (Fig. 6.25; data not shown). Both were able to form a 
complex with Mad and Medea. Sequence alignment with positively tested S3 subconstructs 
reveals a similar configuration of putative Smad binding sites, with slight differences. S7xxs 
exhibits a different arrangement of the Mad/Brinker sites; one main difference in S7xxb is the 
prolonged linker of six nucleotides between the putative Mad sites. 
 
Figure 6.25 
Identification of a minimal binding element. S3 was successively shortened and tested for binding of Mad/Medea/TkvQD cell lysates. A 
construct as small as S3xxs6, including a full Mad/Brinker site and a partial Mad site, was still able to recruit Smad proteins. Rough analysis
of S7 revealed the existence of at least two binding elements with a similar arrangement of putative Mad binding sites, one in S7xxs and one
in S7xxsb (data for S7xxs not shown). 
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6.3.7 The minimal Mad/Medea binding element resembles the SE 
After having defined a minimal Mad/Medea binding element in the dad enhancer, it became 
obvious that this element showed great homology with another well-characterized Dpp 
response element, the Silencer Element (SE) 
(Pyrowolakis et al., 2004). The “red” and 
“blue box” of the SE, recruiting two Mad 
proteins and one Medea protein, respectively 
(Gao et al., 2005), find their counterparts in 
the S3xxs6 construct (Fig. 6.26). All GNC 
motifs shown to be important for Smad 
binding (Shi et al., 1998; Zawel et al., 1998) 
are conserved, as well as the length of the linker. The main differences are the lack of the 
second T in the blue box of S3xxs6, that has been shown to be important for the recruitment 
of the repressor Schnurri (Pyrowolakis et al., 2004), and the fact that S3xxs6 is also able to 
recruit Brinker. 
6.3.8 Definition of the AE consensus sequence 
Since the identified minimal dad Dpp response element resembled so closely the Silencer 
Element, we termed it Activating Element (AE). To test whether similar consensus 
restrictions applied to the AE, we single point mutated every nucleotide within the AE from a 
pyrimidine to a purine base (and vice versa) of the other base pair (e.g. C to A and G to T). 
The mutated constructs were then used in a competition assay with the labeled wild type 
oligonucleotide (Fig. 6.27). The outcome widely reflected the results of Pyrowolakis et al. 
(2004), who did a similar experiment for the determination of the SE consensus sequence. 
Whereas mutating nucleotides of the red box (except of the second position) and the blue box 
reduced the binding strength to different extents, mutations of the linker region had no effect 
on Mad/Medea recruitment. Variation of the linker length still allowed for complex 
formation, albeit with different efficiencies. An oligonucleotide with a four base linker, for 
example, proved to be a worse competitor than one with a six base linker, which bound as 
strong as the wild type oligonucleotide. 
Since the AEs within the dad enhancer are also able to recruit Brinker, we chose the sequence 
GGCGCCANNNNGNCV as a working consensus sequence, thereby merging the AE 
consensus sequence elaborated in Fig. 6.27, the perfect Brinker binding site GGCGCCA and 
the fact that Schnurri should not be able to bind (thus the V, meaning any nucleotide except 
T).  
 
S3xxs6 GTGGCGCCATTCCGACGA 
SE    GRCGNCNNNNNGTCTG 
 
Figure 6.26 
Comparison of the minimal element able to bind Mad and
Medea with the Silencer Element (SE). The so-called “red
box” binds two Mad proteins whereas the “blue box” binds one
Medea molecule. 
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6.3.9 Testing of the spalt and Ubx enhancers for Mad/Medea complex 
formation 
The homeotic gene spalt is one of the better characterized targets of Dpp signaling in the wing 
imaginal disc. The spalt enhancer upstream of the transcription start (Kuhnlein et al., 1997) 
has been shown to be regulated by several transcription factors including Smads (Barrio and 
de Celis, 2004; Galant et al., 2002; Guss et al., 2001). Recently, it has been reported that a 
complex of Ubx, Mad/Medea and Schnurri is responsible for Dpp dependent repression of the 
spalt enhancer in the haltere imaginal disc (Walsh and Carroll, 2007), implying a 
conformation similar to that on the Silencer Element (and thus the Activating Element). For 
this reason we tested the published construct for Mad/Medea binding. Furthermore, we tested 
the Dpp response element from the Ubx enhancer (compare Figures 6.18 and 6.19), since this 
has been shown to be regulated by a similar Brinker/Mad competitive binding (Kirkpatrick et 
al., 2001). Both constructs fulfill neither consensus sequences for the AE nor for the SE. 
Consequently, neither construct was able to induce a supershift when incubated with extracts 
from Mad/Medea/TkvQD-transfected cells (Fig. 6.28), suggesting a different Smad binding 
mechanism for these two Dpp-activated enhancers. 
 
Figure 6.27 
Definition of the AE consensus sequence. Radioactively labeled wild type oligonucleotide of the sequence above was subjected to a
competitive assay with different “cold” point mutated probes and lysates from Mad/Medea/TkvQD transfected cells (first lane non-transfected 
cells as control). Mutations were G to T, C to A and vice versa. Furthermore, oligonucleotides were tested where the linker sequence
(ATTCC) had been modified by either complete mutation (dead) or variation of the length (-1 to +2). 
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6.3.10 Confirmation of the transcription factor binding sites in vivo 
Having defined the sites of repressive Brinker input and activating Mad/Medea input in vitro, 
our next aim was to analyze the activity and expression pattern of mutated forms of the dad 
enhancer in cell culture and in transgenic animals. We created several mutant versions of 
Dad13 to analyze different aspects of the minimal enhancer (see Fig. 6.29 for sequences): 
Dad13m1 included a destroyed tandem Smad binding element. In Dad13m2 the two major 
Brinker/Mad binding sites were destroyed, which affected the AE within S3 (position 111 to 
125) and one of the two AEs within S7 (around position 390, compare Fig. 6.25). Dad13m3 
was an attempt to transmutate all potential Brinker/Mad sites into exclusive Mad sites, as it 
was successfully done in vitro (see Fig. 6.21). In Dad13m4, all three sites identified as 
Brinker sites in vitro were destroyed. Dad13m5 was an alternative construct to Dad13m3 
where different mutations were applied to turn Brinker/Mad sites into Brinker sites (no 
transgenic flies were created for this construct). In Dad13m6 finally, all important (meaning 
conserved and beforehand positively tested) Mad sites were mutated to ensure that all 
functional AEs within Dad13 were destroyed. 
As shown before, Dad13 is able to strongly drive expression of a lacZ reporter gene in 
embryonic and larval tissues as well as in S2 Schneider cells upon co-transfection of plasmids 
encoding ThickveinsQD, Mad and Medea (Fig. 6.29). Destruction of the tandem Smad binding 
element (Dad13m1) had only little effect on the expression levels, suggesting that this site is 
not the most essential one for transcriptional regulation. Mutation of the two major 
Brinker/Mad sites (asterisks 1 and 7; Dad13m2), however, nearly entirely abolished 
expression in the embryo and in transfected cells. Expression in the imaginal discs was 
affected but not completely abrogated. Transmutation of the Brinker/Mad sites into sole Mad 
sites (Dad13m3) was not successful. Instead of observing an expansion of the expression 
domain at comparable strength (caused by elimination of the Brinker input), total expression 
levels were strongly reduced. This was probably due to the nature of the introduced 
Figure 6.28 
Testing of other elements potentially forming a Mad/Medea complex. Dpp response elements from the Ubx and spalt enhancer were 
tested for Mad/Medea recruitment. S3xxs served as a positive control. The Ubx element contains three putative Brinker sites, one of them
also a potential Mad site. Sequence analysis for the spalt element revealed only a Smad binding element (blue), however weak binding of the 
Mad MH1 domain has been reported (Walsh and Carroll, 2007). No supershifts were induced for both the Ubx and spalt element.  
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mutations, since complete destruction of the Brinker sites (asterisks 1, 4, 7; Dad13m4) led to 
an expansion of expression in the imaginal discs, although total expression levels were at the 
same time lower than in the wild type construct. The embryonic expression driven by 
Dad13m4 was weak, comparable with that of Dad13m2. Thus it seems that the expression 
within the embryo (and in transfected S2 cells) relies mainly on the two AEs including the 
two Brinker/Mad sites, whereas the expression in the imaginal discs is to a large extent based 
on the third AE. In Dad13m6, all putative Mad sites were mutated, including all possible AEs. 
Consequently, expression was nearly gone in the embryo. Also in the wing imaginal disc, 
expression driven by Dad13m6 was strongly reduced, though not completely abolished. The 
residual expression might either be due to AE-independent input (as the SBEs) or the fact, 
that the AEs were not sufficiently mutated. To investigate this issue, we plan to focus on the 
smaller construct Dad16 (see Fig. 6.5), that encompasses only the 5’ cluster of Brinker/Mad 
binding sites. Dad16 is expressed similarly to Dad13, at only marginally lower levels (data 
not shown). The fact that it includes probably only one AE should facilitate mutation analysis 
to a large extent. 
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Figure 6.29 
Analysis of Brinker/Smad binding sites in vivo. The schematic drawing of full length Dad13 shows all theoretical Brinker and Smad sites, 
numbered from 1 to 9. Sites 2, 4 and 7 have been shown to be Brinker sites in vitro. Site 2 is included in the identified AE, two more AEs 
were found within the cluster of sites 6 to 8 (compare Fig. 6.24). Different mutant constructs (Dad13m1 to Dad13m6) were analysed in the 
embryo, larval discs and by measuring the expression of βgal in transfected S2 Schneider cells. The results confirmed the in vitro data to a 
large extent. Expression in embryos and larval discs was detected by anti-βgal and XGal staining, respectively. 
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6.3.11 Functional dissection of the AE in vivo 
After having discovered the AE as the activating twin of the Silencer Element and having 
demonstrated that it is essential for expression of the dad minimal enhancer, we wanted to 
know whether the AE was sufficient to read out Dpp signalling in vivo. Earlier attempts to 
multimerize simple Smad binding elements and thus replicate expression patterns of BMP 
regulated genes were not successful (Guss et al., 2001), although such constructs are generally 
able to confer responsiveness in cell culture experiments. This is considered as a consequence 
of the observation that Smad proteins normally act in concert with other transcription factors 
(Feng and Derynck, 2005; Shi and Massague, 2003). Furthermore, activation via Smads (as 
via signal-activated mediators in general) is supposed to depend on the existence of binding 
sites for local co-activators, a phenomenon referred to as cooperative activation (Barolo and 
Posakony, 2002). This made it unlikely that singular Smad binding sites outside a certain 
regulative context allowed for complex regulation. 
However, we found that the AE binds not only a single factor but a complex of Smad 
proteins, which is unique and has so far not been demonstrated for any gene activated by Dpp. 
Since the dad gene follows Dpp expression closely and the existence of Mad and Medea is 
not restricted to specific tissues, we were tempted to speculate that the AE is sufficient to read 
out Dpp signalling. To determine this, we created a pentamerized version of the AE (5xAE, 
see Fig. 6.30), fused in front of a lacZ reporter. The sequence we chose was largely based on 
the first AE from the dad locus. In addition, we created three other pentamerized constructs: 
5xHASE, 5xSE and 5xNASE. 
HASE (Hyperactivated Activating/Silencer Element) is a mutated version of the AE with a 
single mutation that changed the Brinker/Mad site to a Mad site only. This construct was 
supposed to confer only activating Dpp responses and no Brinker input. 
SE is able to recruit Mad/Medea as well as Schnurri. Binding of Schnurri depends on the 
second T within the GTCTG sequence (Affolter and Basler, 2007; Pyrowolakis et al., 2004). 
The chosen construct does not fulfill the Brinker binding consensus sequence and should thus 
not be able to recruit Brinker. 
NASE (Nullified Activating/Silencer Element) is another chimeric construct, which includes 
both the nucleotides important for Schnurri binding as well as a perfect Brinker site. In other 
words, it possesses two potential sites for repressive input, one via Dpp signalling and one via 
the default repressor Brinker. 
As hoped for, 5xAE was able to recapitulate the dad pattern in a surprisingly accurate manner 
in the later embryo (Fig. 6.30A). This included expression in two ectodermal stripes, in the 
gut as well as in anterior head structures. 5xHASE, lacking the Brinker site, was activated 
weaker, but much wider, in line with the expected derepression (Fig. 6.30E). 5xSE did not 
induce any staining at all and the same held true for 5xNASE (Fig. 6.30, I and M). 
Since it had been demonstrated that the linker length does not influence Mad/Medea complex 
formation in vitro, we also tested a construct with a linker of only four nucleotides, 5xAE-1. 
The expression pattern induced by 5xAE-1 very much resembled that of 5xAE (Q), with only 
weaker expression in the two ectodermal stripes. This indicates a certain amount of flexibility 
for the AE also in vivo - unlike for the SE, which strictly depends on a linker length of five 
nucleotides to exert its repressive function. This is due to the requirements for Schnurri 
recruitment and raised the question whether changes in linker length could turn the SE into an 
activating motif. To investigate this, we extended the linker by one nucleotide and created the 
construct 5xSE2+1. Indeed, 5xSE2+1 behaved totally different from 5xSE and acted in the 
embryo similarly to 5xHASE (R). This demonstrates again that the SE has the intrinsic 
potential for activation and is repressive mainly due to recruitment of Schnurri. In addition, 
the results for 5xAE-1 and 5xSE2+1 suggest that Schnurri is not involved in AE-mediated 
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activation, or at least only by a binding mechanism completely different from that of 
SchnurriCT. 
From the outcome of our experiments so far we conclude that the AE is a Dpp dependent 
activating element, which also reads out repressive input via Brinker. In contrast, the SE is a 
purely repressive element, merely regulated by Dpp and Schnurri and not (directly) by 
Brinker. To prove this, we tested the behavior of the pentamerized constructs upon ectopic 
expression of different effectors (Fig. 6.30). Indeed, striped expression of Brinker leads to 
local repression of 5xAE, but not 5xHASE. Since 5xNASE, which should also be able to 
recruit Brinker, is already off, no effect could be seen upon expression of Brinker, as was the 
case for 5xSE. This reflects a general problem when searching for repressor binding sites - 
they can only be analysed in the context of an activator. A repressive element per se does not 
induce expression, thus destruction of it will not lead to visible changes. To circumvent this 
fundamental problem, we again made use of BrkVP16, where the repression domain of the 
Brinker protein was swapped with an activation domain. Striped expression of BrkVP16 not 
only confirmed the results of ectopic Brinker expression (strong activation of 5xAE and only 
very weak activation of 5xHASE), but also revealed that 5xNASE was indeed functional and 
able to bind the Brinker DNA binding domain in vivo (Fig. 6.30), as postulated. 
Finally, we also tested ShnVP16, a similar fusion protein of the SchnurriCT complex 
formation domain and the VP16 activation domain (created by Britta Hartmann). As 
Figure 6.30 
Functional dissection of the AE. Several different constructs based on the AE and the SE were oligomerized and fused to a lacZ reporter 
gene. Mad sites are depicted in red (“red box”), Brinker sites in green and Medea sites in blue (“blue box”). Expression was detected using
an anti-βgal antibody. Four constructs were tested in mutant backgrounds. The first column shows the wild type expression, the second to
fourth columns the situation in mutant embryos expressing Brinker, BrinkerVP16 and SchnurriVP16, respectively, under the control of the 
paired enhancer. (A to D) 5xAE, (E to H) 5xHASE, (I to L) 5xSE, (M to P) 5xNASE. Also shown is the expression of two constructs with
variant linker length (Q, R). The expression patterns of dpp (S) and dad (T) (detected by in situ hybridization) are depicted as a comparison. 
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expected, only 5xSE and 5xNASE showed ectopic activation, since only they meet the 
requirements for Mad/Medea/Schnurri complex formation. No effect was seen for 5xHASE – 
unlike for 5xAE that showed local repression where ShnVP16 was expressed. This can be 
explained by the upregulation of brinker via its own endogenous SEs and again confirms the 
Brinker binding to the AE. 
Taken these results together, we managed to dissect and separate the regulative inputs on the 
initially identified SE and the novel AE. With the two newly created elements HASE and 
NASE, we now have four different elements at hand that individually read out combinations 
of Smad-mediated activation (AE and HASE), Schnurri/Smad-mediated repression (SE and 
NASE) and Brinker-mediated repression (AE and NASE). 
Our initial plan was to identify an element ubiquitously responsive to Dpp. Consequently, we 
examined the AE and derived constructs also in the imaginal discs. Yet, the situation in the 
wing disc differs dramatically from the embryo (Fig 6.31). 5xAE does not induce any 
expression of the lacZ reporter gene in the imaginal discs. However, hyperactivation of the 
Dpp pathway by expression of tkvQD under the control of the pouch-specific nubbin enhancer 
is sufficient to generate low levels of expression. This indicates that the 5xAE is in principle 
functional also in the wing disc. As it was expected, also for 5xNASE no expression could be 
detected. But surprisingly, 5xHASE (that differs from 5xAE by only five times a single 
nucleotide) induced a strong expression in the wing pouch. This drastic change in expression 
could hardly be explained by removal of the Brinker binding site. A closer look at 5xHASE 
revealed, that it fulfills to a large extend the consensus binding sequence of the pouch-specific 
activator Scalloped (Fig 6.32), a TEA-domain transcription factor (Campbell et al., 1992) 
reported to bind in complex with Vestigial 
to wing-specific enhancers (Halder and 
Carroll, 2001; Halder et al., 1998). It now 
has to be examined whether Scalloped is 
also important for regulation of the “wild 
type” sequence 5xAE and the dad 
enhancer. 5xSE shows expression only in 
the most lateral regions of the wing pouch, 
which can be easily explained by 
activation analogous to 5xHASE and 
repression within the Dpp domain. 
However, 5xSE2+1, with an extended linker and an additional nucleotide in the putative 
Scalloped binding site, does not show any expression in the imaginal discs (data not shown). 
This might be caused by impaired Scalloped binding. To further investigate this issue, our 
next step will be to mutate the linker composition of 5xHASE and analyse the effect on 
expression in the wing disc. 
Figure 6.31 
Expression of 5x constructs in the wing disc. 5xAE and 5xNASE do not induce any lacZ expression in the imaginal discs (A, C). However, 
hyperactivation of the Dpp pathway in the wing pouch (by expression of tkvQD under the control of the nubbin enhancer) can induce lacZ
expression at low levels (B). 5xHASE showed very strong expression in the wing pouch (D), which might be due to binding of the activator
Scalloped. Consistently, 5xSE induces lacZ expression only in the lateral pouch regions most distant to Dpp expressing cells (E). All images
show XGal stainings. 
 
NASE
C
AE
A
HASE
D
SE
E
AE nub>tkvQD
B
AE      ACTGGCGCCATTCCGACGA 
HASE    ACTGGCGACATTCCGACGA 
SE2+1   ACTGGCGACATTTCCGTCTGA 
 
SBS          CACATTCCT 
 
Figure 6.32 
Comparison of AE, HASE, SE2+1 and the Scalloped binding site.
Six (AE) and seven (HASE) out of nine nucleotides fulfill the 
Scalopped binding site (SBS) published by Halder et al. (1998). 
SE2+1 does not, due to the introduced linker mutation. 
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6.3.12 Search for co-activators acting on the AE 
The question remains whether Mad/Medea recruit any co-activator to the AE in order to 
activate gene expression. One possibility to address this issue is an approach based on 
mass spectrometry. To test the feasibility of this task, we performed a test experiment. 
Biotinylated 3xAE bound to Streptavidin Sepharose beads specifically co-precipitated 
phosphorylated Smad when incubated with extracts from HEK293 cells transfected with 
Mad/Medea/TkvQD (Fig. 6.33). This result suggests that it is generally possible to isolate 
proteins bound to the AE. The next step would be to apply lysates from Drosophila embryos 
instead of cell extracts and subject the bound and later eluted proteins to mass spectrometry.  
HEK293 cells possess an active BMP pathway and it has been shown that vertebrate Smads 
can bind to the SE (Hartmann, 2004). Since the antibody is directed against human p-Smad, it 
thus can not be excluded that the specific band results from human Smad binding to the AE, 
either upon phosphorylation by TkvQD or by forming a complex with transfected Mad/Medea. 
Figure 6.33 
Co-precipitation of pSmad. Biotinylated 3xAE 
was coupled to Strepdavidin Sepharose beads, 
incubated with extracts from Mad/Medea/TkvQD
transfected HEK293 cells and after washing 
subjected to SDS gel electrophoresis. pSmads were 
detected using an antibody directed against human 
phospho-Smad. Non-transfected lysates and a 
mutated AE served as controls. 
Significant binding was only observed for 3xAE, 
and when effectors were transfected. 
Mad/Medea/TkvQD +  ·   +  ·   +  ·
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6.4 Identification of novel Dpp activated enhancers 
6.4.1 In silico screen for AEs 
To test whether functional AEs can also be found in the enhancers of other genes, we 
performed an in silico screen, taking advantage of the freely accessible research tool 
http://www.flyenhancer.org (Markstein et al., 2002). An initial search with the sequence 
GGCGCCANNNNGNCV delivered 770 hits. From these hits we picked genes that were 
either known to be associated with Dpp regulation or to have an expression pattern similar to 
that of dad and dpp. For this we consulted relevant publications and the BDGP in situ 
database at http://www.fruitfly.org (Tomancak et al., 2002). Next we checked whether the 
potential AEs were conserved in other Drosophila species, using the VISTA Genome 
Browser. We finally concentrated on 22 enhancer fragments with potential AEs and designed 
constructs of approximately 2kb, including 1kb upstream and 1kb downstream of the AE. 
Table 6.1 shows an overview of the constructs with length and positions within the genome 
annotation 4.1 (released April 2004 and used by the Flyenhancer tool and CAF1 assemblies) 
and the latest available annotation 5.6 (released March 2008). It also indicates whether an 
expression pattern was observed for the cases where transgenic flies were obtained. In 
addition to the potential AEs listed, we also found another putative AE in the fifth intron of 
the dad locus. In the following, we describe in some detail the results we obtained by 
analysing the above-mentioned enhancers. 
 
Table 6.1 Overview of potentially AE-regulated enhancers chosen for analysis 
 
# Name Start Start Length Expression 
  (Release 4.1) (Release 5.6) (kb) Discs Embryo 
01 ATET chr2L:4337609 ~ 2.4 
02 Bnl chr3R:15636965 ~ 2 
03 Btl-1 chr3L:14036438 14064279 2.6 
04 Btl-2 chr3L:14039022 14066863 2 ? no 
05 Cv2-1 chr2R:16867350 17247273 2 no no 
06 Cv2-2 chr2R:16873613 17253536 2.5 no yes 
07 Doc-1 chr3L:8988927 9008080 2.9 yes yes 
08 Doc-2 chr3L:9006231 9025384 2 yes yes 
09 Doc-3 chr3L:9011012 9030165 2 yes yes 
10 Doc-4 chr3L:9016146 9035299 1.2 yes yes 
11 Elb-1 chr2L:14400957 ~ 2 no yes 
12 Elb-2 chr2L:14403002 ~ 1.9  
13 Hiw-1 chrX:14848199 14908295 2.6 ? no 
14 Hiw-2 chrX:14850771 14910867 3 
15 Hiw-3 chrX:14866918 14927014 2 
16 Hiw-4 chrX:14886905 14947001 2 ? no 
17 Indy-1 chr3L:18794692 18822533 2 
18 Indy-2 chr3L:18813198 18841039 2 
19 Kni-1 chr3L:20611632 20670891 2 ? yes 
20 Kni285 chr3L:20635383 20694642 2 ? yes 
21 Pnr-1 chr3R:11845930 ~ 2 yes yes 
22 Ap chr2R:1242540 1622657 3 no yes 
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6.4.2 Crossveinless-2 
Crossveinless-2 (Cv-2) is an extracellular modulator of BMP signalling (Conley et al., 2000) 
with high similarity to Short gastrulation (Sog), that is known to bind Dpp and other BMP-
like ligands and contribute to the formation of a dorso-ventral Dpp activity gradient in the 
early Drosophila embryo (Eldar et al., 2002; Srinivasan et al., 2002). Also Cv-2 might be 
involved in this regulatory network (Biemar et al., 2006), its function (as the gene name 
implicates), however, is better analysed in the formation of the cross vein in the developing 
wing disc (Conley et al., 2000). Recent studies have revealed that Cv-2 works as Sog in a bi-
phasic manner, promoting Dpp signalling in small concentrations and inhibiting it in high 
concentrations. Cv-2 is able to restrict the binding of BMP ligand to its receptor by blocking 
the binding sites (Zhang et al., 2008a). Furthermore, Cv-2 is able to interact with cell-surface 
proteins and the BMP receptors (Serpe et al., 2008). cv-2 enhancer traps show expression 
along the anterior-posterior border of the wing disc and dorsal regions of leg and eye-antennal 
disc (Fig. 6.34; Conley et al., 2000), which overlaps with dpp expression domains. 
Furthermore, it has been shown that cv-2 expression in the posterior cross-vein is regulated by 
the BMP ligand Gbb (Serpe et al., 2008). Three putative AEs were found in the cv-2 locus, 
two next to the transcription start (AE6 in Fig. 6.34) and one within the largest intron (AE5). 
The potential AE in AE5 is perfectly conserved in D. pseudoobscura and D. virilis, one of the 
AEs in AE6 in D. pseudoobscura and partially in D. virilis. 
To our disappointment, neither AE5 nor AE6 showed expression in larval imaginal discs (data 
not shown). For AE5, due to its high conservation a promising candidate, no specific staining 
could be observed in the embryo either (Fig. 6.35, G to I). This was not the case for AE6. 
AE6 is expressed already in the early gastrulating embryo anteriorly and in a broad dorso-
lateral domain (J, K). Later, expression refines to a segmented lateral stripe and increases 
anteriorly (L). In the older embryo, two stripes become visible (M, N), though the specific 
expression in the leading edge of dorsal closure is most striking (O). To test whether the 
Figure 6.34 
Genomic locus and expression of cv-2. The cv-2 gene is located on the second chromosome. Two reporter constructs, AE5 and AE6, were 
designed, including three potential AEs. Two lacZ enhancer traps positioned in the first (3511) and second intron (225-3) show expression 
within the anterior-posterior border of the wing imaginal disc as well as dorsal regions of the leg and eye-antennal disc. Figures A to C 
adapted from Conley et al (2000).
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Brinker site in AE6 was functional, we expressed BrkVP16 under the control of the paired 
enhancer. This led to an ectopic striped expression (R, S), indicating that Brinker indeed binds 
to AE6. 
 
Figure 6.35 
Expression of cv-2 reporter constructs AE5/AE6 and enhancer trap. AE5 does not induce any expression in the embryo (G to I). AE6 
mediated lacZ expression (J to O) differs in several aspects from that of the enhancer trap cv-2225-3 (A to C). Unlike all other tested AE 
enhancers, AE6 induces lacZ expression already as early as stage 6 (J). The most prominent feature is the strong staining within the leading
edge cells of the late embryo (O). Striped expression of a transgene encoding BrinkerVP16 is able to ectopically activate AE6 (R, S). All 
embryos were stained using an anti-βgal antibody. 
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6.4.3 Elbow B 
The elbow B (elb) gene encodes a nuclear zinc finger protein and is expressed in the tracheal 
pits and later in a specific subset of tracheal cells (Dorfman et al., 2002). Embryos mutant for 
elB show a tracheal phenotype similar to that caused by defects in the Dpp pathway. 
However, an interaction of Dpp and Elb or a mutual dependence could not be found (Dorfman 
et al., 2002). Two potential AEs were identified within the largest intron of the elB gene, both 
conserved in D. pseudoobscura. We designed two constructs, AE11 and AE12, centered on 
each AE (Fig. 6.36). While expression data for AE12 is not yet available, AE11 shows a 
strong expression in the ectoderm and mesoderm, which initiates at the beginning of germ-
band retraction. Two initially distinct stripes fuse to give rise to a wide lateral stripe that also 
encompasses the Brinker domain (Fig. 6.36). This was surprising. A closer look at AE11, 
however, revealed that the AE there carries the non-perfect Brinker site AGGCGTC, instead 
of (T)GGCGCC, and thus might not be sensitive to Brinker regulation. This proved to be the 
case - ectopic expression of both Brinker and BrinkerVP16 under the control of the paired 
enhancer had no effect on the expression of AE11. Further investigations have to be carried 
out, but chances are high that the AE11 thus contains a natural HASE – an AE that lacks the 
Brinker binding site.  
 
 
 
Figure 6.36 
Expression of  the elB enhancer construct AE11.  After stage 10, AE11 is expressed in two distinct lateral stripes (A) that soon fuse to one 
wide stripe (B, C). The expression of AE11 is independent of Brinker, as shown by the ectopic expression of Brinker and BrinkerVP16 (D to
F show representative embryos). All embryos were stained using an anti-βgal antibody. 
AE11
AE11
representative for prd Gal4 x UAS Brk / BrkVP16
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6.4.4 Dorsocross 
The Dorsocross gene cluster consists of three closely related genes (Dorsocross1, 
Dorsocross2 and Dorsocross3) of redundant function that code for transcription factors of the 
T-box protein family. Dorsocross has been shown to act downstream of Dpp (Hamaguchi et 
al., 2004; Reim et al., 2003) and was considered a candidate for a gene directly regulated by 
Dpp. The gene name results from its characteristic dorsal cross-like expression in the early 
embryo. Later, Dorsocross is expressed in a fashion similar to dad, in two metameric stripes 
(Fig. 6.37). Also in the wing imaginal disc Dorsocross is expressed along the anterior-
posterior border like dad (Fig. 6.37). However, expression is not continuous, since 
Dorsocross is repressed by Wingless (Reim et al., 2003). In no other genomic locus than that 
of Dorsocross, so many potential AEs were found (Fig. 6.37). We designed four constructs 
including five putative AEs, two constructs in the major introns of Doc2 and Doc3 and two 
within their intergenic region. All four fragments were able to activate the lacZ reporter gene 
in both embryo and imaginal discs (Fig. 6.39). None of them completely resembled 
endogenous Doc expression, which indicates a modular organization of the Doc enhancer. 
AE7 and AE10 are expressed in two lateral ectodermal stripes in the embryo, whereas AE9 
displays only the more ventral stripe. AE7, AE8 and AE10 also show a very specific 
Figure 6.37 
Organization of the Dorsocross locus and endogenous expression. The three genes Dorsocross1, Dorsocross2 and Dorsocross3 form the 
Dorsocross locus. They are expressed in a very similar pattern and show redundant function. Dorsocross is expressed characteristically in the 
early embryo in dorsal regions and later in two ectodermal stripes as well as the hindgut (Doc1 in situ hybridization; images adapted from 
Hamaguchi et al., 2004). In the wing disc Dorsocross can be detected along the anterior-posterior border with local repression within the 
Wingless domains (anti-Doc2+3 and anti-Wingless antibodies, image adapted from Reim et al., 2003). 
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individual staining of the hindgut. In the imaginal disc, expression can be seen in dorsal 
domains of leg and eye-antennal disc for AE7, AE8 and AE10 and in the wing and haltere 
discs for AE7, AE8 and AE9. 
Our next aim was to mutate the AE. By this means we hoped to abolish the activity of the 
enhancer constructs. As done before, the core nucleotides of the Brk/Mad site GGCGCC were 
mutated to GGatCC. However, no effect was seen for the two AEs tested, AE7 and AE9 (data 
not shown), neither in the imaginal discs nor in the embryo. Since the linker length of the AE 
was shown to be flexible, this could be explained with the existence of more AEs. To 
decrease the number of additional candidate sites we first reduced the size of AE7 from 2.9kb 
Figure 6.39 
Expression of the AE7 subconstruct AE7-600. Compared to AE7, expression in leg and eye-antennal discs is lost (F to H), as well as in the 
embryonic hindgut (A to D). Expression in the wing dics is expanded (E). All embryos were stained using an anti-βgal antibody, discs using 
an XGal protocol. 
AE7-600
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Figure 6.38 
Expression of Doc enhancer constructs AE7 to AE10. All constructs induce expression in tissues and regions known to be exposed to Dpp
signalling, in the embryo as well as larval imaginal discs. All embryos were stained using an anti-βgal antibody, expression in discs was 
detected by XGal stainings. 
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to less than 600bp (position 1458 to 2038). This construct, AE7-600, differed in its expression 
from AE7, as it was not active anymore in the embryonic hindgut and in larval leg and eye-
antennal discs (Fig. 6.39). Expression in the wing disc was expanded, suggesting the removal 
of repressive sites. In the embryo, the expression in two ectodermal stripes was maintained. 
Still, also mutation of AE7-600 did not result in changes in the wing disc expression (the 
analysis of the embryonic expression is pending). A look on the sequence of the AE7-600 
construct revealed again the existence of further AE-like sequences (Fig. 6.40). Striking was 
the high number of Smad binding elements (SBEs), since the dad minimal enhancer only has 
two of them. However, only one SBE is conserved in other distantly related Drosophila 
species (Fig. 6.40). In the next step, we plan to test an even smaller construct, AE7-300, 
which includes the initial potential AE and excludes two other possible AEs that differ in 
linker length and composition of the Brinker/Mad site (Fig. 6.40).  
 
 
 
 
 
 
  
 
 
 
 
Figure 6.40 
Putative transcription factor binding sites in AE7-600. The initially identified AE is depicted in orange, AE-like sequences in pink, 
putative Brinker sites in green and SBEs in blue. The high number of SBEs is striking and exceeds the average statistical number by three. 
The position of a smaller construct AE7-300 is indicated by arrows. Asterisks mark bases conserved in D. pseudoobscura, mojavensis and 
virilis. Position 1 refers to position position 1458 in AE7.
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6.4.5 Knirps 
The knirps gene belongs to the group of zygotic gap genes and encodes a zinc finger 
transcription factor (Rothe et al., 1989). It has been intensively studied for its role in 
patterning the early embryo. However, it also functions in the formation of the tracheal 
system later in embryogenesis, where it mediates Dpp-regulated cell migration, together with 
its close homolog knirps-related (knrl) (Chen et al., 1998). Two potential AEs, perfectly 
conserved in D. pseudoobscura and D. virilis, were found in the kni locus, one upstream of 
kni in proximity to the stripe-enhancer (Pankratz et al., 1992) and one between the kni and 
knrl genes, 18kb downstream of kni (Fig. 6.41). Both enhancer constructs showed trachea-
specific expression. Whereas AE19 was expressed in ventral cells of the trachea placodes and 
branches and the visceral branch, AE20 was expressed in both dorsal and ventral cells of 
trachea placodes and branches. To analyse the dependence of AE20 on Smad and Brinker 
input, we introduced several kinds of mutations. In one construct we intended to destroy the 
enhancer activity by mutating the core nucleotides of the Brinker/Mad site (AE20AEd). In the 
second we introduced nucleotides shown to be important for Schnurri recruitment, thus 
transforming the AE into a repressive SE (AE20SE). The third mutation aimed to convert the 
Figure 6.41 
Expression of kni and the enhancer constructs AE19 and AE20. Two constructs AE19 and AE20 were designed, with AE20 based on 
unpublished data provided by Reinhard Schuh. kni and knrl are expressed in the tracheal placodes and later in the cells of dorsal, visceral,
and lateral trunk and ganglionic branches (images A, B, C kni in situ hybridization, adapted from Chen et al., 1998). The expression patterns 
of AE19 and AE20 reflect aspects of the endogenous kni expression, with AE19 expressed in cells of the ventral placodes and branches as 
well as in the visceral branch, and AE20 expressed in cells of dorsal and ventral placodes and branches. All embryos were stained using an 
anti-βgal antibody. 
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putative Brinker/Mad site into an exclusive Mad binding site (AE20BtM). As seen in 
Figure 6.42, expression of the reporter gene was strongly reduced upon destruction of the AE 
(B) and completely gone when the AE was turned into an SE (C). Strikingly, our attempt to 
remove the Brinker input without destroying the Mad site resulted in a dramatic expansion of 
the expression pattern (D). Reporter expression was not only detected in the dorsal and 
ventral branches (though at slightly lower levels), but also in the connective trachea, as the 
dorsal trunk, where Brinker is active (Markus Affolter, personal communication). To further 
test the functionality of the Brinker binding site, we expressed the strong activator 
BrinkerVP16 under the control of the paired enhancer. The result was a striped ectopic 
upregulation of the wild type enhancer as well as the mutated version, where the AE was 
converted into an SE. This strongly indicated the existence of a Brinker binding site and 
demonstrated the integrity of the SE construct. Altogether, our results suggest that the AE of 
this enhancer is an important site for regulative activating input. 
 
Figure 6.42 
Expression of mutated forms of AE20. The AE within this only 285bp large enhancer construct was mutated in three different ways.
Destruction of the AE (B) strongly reduced expression levels, while conversion of the AE into a repressive SE completely abolished them
(C). Mutations that turn the Brinker/Mad site into a pure Mad site led to a drastic expansion of the staining into the dorsal trunk (D). Striped
expression of BrkVP16 induced ectopic reporter gene expression in the wild type construct (E) as well as in the otherwise non-active SE 
construct (F). Asterisks mark mutated sites. All embryos were stained using an anti-βgal antibody. 
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6.4.6 Pannier 
The pannier (pnr) gene encodes a zinc finger transcription factor of the GATA family 
(Ramain et al., 1993; Winick et al., 1993). Its function has been analysed mostly in the wing 
imaginal disc, where it is expressed in the presumptive notum, which forms the dorsal 
mesothorax of the adult fly. Within the notum, Pannier is involved in a regulatory network 
with Dpp, Wingless and U-Shaped (Calleja et al., 1996; Sato et al., 1999; Sato and Saigo, 
2000; Tomoyasu et al., 2000), where Dpp regulates wg by induction of pnr. Overexpression 
of the constitutively active Dpp receptor TkvQD induces ectopic pnr expression, whereas 
expression of pannier is mostly lost in Tkv mutant clones (Sato and Saigo, 2000; Tomoyasu et 
al., 2000). pnr is also expressed in dorsal regions of the eye-antennal disc (Heitzler et al., 
1996). In the embryo, pannier plays an important function in heart development (Gajewski et 
al., 1999). It is also involved in formation of dorsal ectoderm and amnioserosa (Heitzler et al., 
1996; Winick et al., 1993) where it is regulated by Dpp (Ashe et al., 2000) and later itself 
activates dpp in cells necessary for dorsal closure (Herranz and Morata, 2001). Furthermore, 
pnr expression expands in early brinker mutant embryos (Jazwinska et al., 1999b) 
Two potential AEs were found in the pannier locus, upstream and downstream of the largest 
pnr transcript (Fig. 6.43). The first one is perfectly conserved in D. pseudoobscura and D. 
virilis and situated within a 5.6kb fragment shown to be genetically regulated by Dpp and to 
reflect several aspects of endogenous pnr expression in wing disc and the older embryo 
(Fromental-Ramain et al., 2008). Expression of the respective construct AE21 could be 
observed in the presumptive notum of the wing imaginal disc and in the center of the wing 
pouch, presumably where dpp and wg expression domains meet (Fig. 6.44). This dot-like 
expression does not reflect the endogenous expression. Furthermore, AE21 was expressed in 
the dorsal-most regions of haltere and eye-antennal discs. In the embryo, expression can not 
be detected before germ-band retraction. AE21 is strongly expressed in the dorsal-most cells, 
later a second, weaker lateral stripe becomes evident, which is not included in the endogenous 
pnr expression and might reflect the lack of (Brinker) repressor sites resulting from the design 
of AE21. 
 
 
 
 
Figure 6.43 
Genomic locus of pannier. The pannier gene on the third chromosome encodes for two differently regulated transcripts (Fromental-Ramain 
et al., 2008). Two putative AEs, were identified. The 2kb enhancer construct AE21 surrounding the better conserved AE is situated between
pnr and the neighboring gene GATAe. 
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Figure 6.44 
Endogenous pnr expression and AE21 expression. Images c to h, q and r are adapted from Heitzler et al. (1996) and show endogenous 
embryonic pnr expression (in situ hybridization) and imaginal disc XGal staining of a pnr enhancer trap. AE21 resembles several aspects of 
the pnr expression in the imaginal discs (A, B) and the embryo (C to H), although expression in the early embryo before germband extension 
is lacking. All embryos were stained using an anti-βgal antibody, discs using an XGal protocol.
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6.4.7 Another dad enhancer 
When we performed the in silico search for other AEs in the Drosophila genome, we 
surprisingly detected another putative AE in the dad locus, at the beginning of the fifth intron 
(Fig. 6.45). The 1kb enhancer construct DadInt52 including this AE drives the lacZ reporter 
gene in a very characteristic manner in both larval imaginal discs and the embryo. Expression 
in the wing and haltere imaginal discs resembles the expression of the Dpp target gene 
Dorsocross (Fig. 6.45, compare Fig. 6.37). In the embryo, DadInt52 induces expression of the 
lacZ reporter gene in the head region as well as in endodermal cells, similarly to lab550, a 
known Dpp-regulated enhancer found upstream of the labial gene (Grieder et al., 1997; Marty 
et al., 2001). Furthermore, expression is found the hindgut and in four characteristic spots in 
proximity to the posterior spiracles and the anal plate. No ectodermal striped expression as for 
the minimal Dad13 enhancer can be detected. 
We again applied the same mutations to DadInt52 as before to the knirps enhancer and other 
constructs, first mutating the core nucleotides of the Brinker/Mad site of the AE from 
GGCGCC to GGatCC for complete destruction (termed AEd), and second introducing the 
nucleotides required for Schnurri recruitment (Fig. 6.46) (termed SE). The effect was striking 
in both larval and embryonic tissues. Expression in all imaginal discs decreased dramatically 
upon mutation of the AE and was totally abolished, when the AE was turned into an SE. In 
the embryo, expression was lacking nearly completely for the construct with the destroyed AE 
and entirely for the one with an introduced SE, except of the characteristic four spots at the 
posterior end that remained unaffected for both constructs. This expression is most probably 
Dpp-independent, but served as an internal control that the reporter gene was indeed 
inducible. 
Figure 6.45 
Expression of a different enhancer found in the dad locus. The enhancer construct DadInt52 contains another AE found in the fifth intron
of the dad gene. Its expression pattern differs from that of Dad13, but partially overlaps. DadInt52 drives expression of a lacZ reporter in the 
embryo and in larval imaginal discs. All embryos were stained using an anti-βgal antibody, discs using an XGal protocol. 
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In summary, the AE identified within this enhancer is crucial for its functionality. Mutation of 
as few as two or three out of one thousand nucleotides is sufficient to completely abolish its 
activity.  
 
6.5 The function of the AE is pylogenetically conserved 
The AE resembles the SE-like (but activating) BMP response elements (BREs) found in the 
context of BMP-regulated vertebrate genes (see 4.4.2) and it has been reported that a BRE in 
the Xenopus Vent2 promoter is able to recruit Drosophila Mad/Medea and respond to BMP 
signalling in vivo when oligomerized (von Bubnoff et al., 2005; Yao et al., 2006). 
Given this background, we were interested to find out whether the 5xAE, shown to be able to 
read-out BMP signalling in Drosophila, also induced expression of a lacZ reporter gene in a 
vertebrate model organism. Linearized plasmids used for the transformation of Drosophila 
embryos were injected into 1- to 2-cell zebrafish embryos. At approximately 60% epiboly, 
embryos were fixed and lacZ activity was determined by an XGal staining. 5xAE as well as 
5xSE led to ventral expression of the reporter gene within the BMP2/4 domain (Fig. 6.47), 
indicating a role of BMP in the activation. To verify this, we applied Dorsomorphin, a drug 
identical to the AMP-activated Kinase (AMPK) inhibitor Compound C, to the developing 
embryos. Dorsomorphin has been shown to specifically counteract BMP-mediated 
phosphorylation of Smad1, 5 and 8 (Yu et al., 2008) and thus BMP target gene activation. 
Indeed, we registered a dramatic decrease in activity for 5xAE, while the expression domain 
remained unchanged (Fig. 6.47). 
 
Figure 6.46 
Expression of DadInt52 mutants. Destruction of the Mad/Brinker site (AEd) almost abolished the expression of the lacZ reporter gene in 
imaginal discs (C) and the embryo (D), while transformation of the AE into a repressive SE completely removed it (E, F). Only expression in
the posterior domains next to the anal plate remained unaffected in the embryo (D, F).  All embryos were stained using an anti-βgal antibody, 
discs using an XGal protocol. 
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Figure 6.47 
Expression of 5xAE and 5xSE in zebrafish embryos. (A) The schematic drawings of a 60% epiboly zebrafish embryo show the BMP2/4 
distribution from the animal pole and a lateral view. A lacZ reporter gene driven by 5xAE (B) or 5xSE (C) is expressed within the BMP 
domain, which is also statistically confirmed. Application of the BMP inhibitor Dorsomorphin does not alter the expression pattern, but 
strongly reduces expression strength. Embryos were stained using XGal and photographed from the animal pole. 
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7 Discussion 
7.1 The genetic basis of evolution 
The discovery of genes as units of inheritable information, the identification of the DNA as 
the carrier of these genes and the subsequent cloning of protein coding sequences from 
various organisms quickly led to the widespread belief that it was significant variations in 
these genes that could explain the morphological differences between distinct animals. 
Accordingly, a fruit fly would possess completely dissimilar proteins (and thus genes) than a 
cow. And the driving force of evolution would be the constant development of new genes 
with novel functions, by duplication, alteration and mutation of pre-existing ones. 
With the dramatic increase in sequence data and the subsequent successful sequencing of 
whole genomes, however, it became evident that genes in different animals were not as 
dissimilar as they were thought to be. The same genes were found to control development and 
morphogenesis in phylogenetically distant species, and proteins were shown to have 
conserved functions in animals whose last common ancestor lived several hundred million 
years ago. The mouse Pax-6 protein, for example, is able to induce eye formation in 
Drosophila, like the Drosophila homolog Eyeless (Halder et al., 1995). And human BMP-4 
can rescue the early patterning defects of dpp mutant fly embryos (Padgett et al., 1993). In 
fact, it turned out that signalling pathways involved in development and form-giving 
processes are highly conserved over the whole metazoan kingdom. 
More recent studies revealed that morphological differences among animal taxa were more 
due to variations in the cis-regulatory elements and transcriptional control than differences in 
coding sequences (reviewed in Carroll, 2008). One example where this has been demonstrated 
in great detail is the divergent body pigmentation pattern of two closely related Drosophila 
species. The different morphology was tracked down to a mutation in one specific cis-
regulatory element of the tan gene, whereas the tan protein sequence was unchanged (Jeong et 
al., 2008). New microarray screens and more powerful bioinformatic techniques draw the 
image of large regulatory networks in which each transcription factor controls the expression 
of hundreds of genes. It is obvious that any mutation in the DNA binding behavior of a 
transcription factor would lead to a drastic change (if not collapse) of the respective 
regulatory network. This is evolutionary unfavorable and most probably the reason why the 
function of transcription factors tends to be substantially better conserved among distant 
species than that of other proteins. 
Rather than by introducing mutations into DNA-binding proteins, evolutionary changes can 
be achieved more subtly by mutations in the respective binding sites. Remodeling of existing 
regulatory sequences or the transfer of spatially distant cis-regulatory elements by genomic 
rearrangement can suddenly put a gene under the control of a hitherto not associated 
signalling pathway or abolish an existing linkage, without affecting the whole regulatory 
network. Instead of creating completely novel genes and functions, organisms are thus able to 
recruit existing genes to another context. The recurring redeployment of basically every 
signalling pathways and transcription factor during Drosophila development is a well-studied 
phenomenon. The Dpp pathway, for example, is important for dorso-ventral patterning of the 
embryo as well as growth and patterning of larval imaginal discs (Spencer et al., 1982). And 
the transcription factor Knirps does not only function as a zygotic gap gene, but is also crucial 
for development of the tracheal system (Chen et al., 1998; Rothe et al., 1989). 
The dissection of an enhancer in the attempt to gain molecular understanding of the regulatory 
input is a tedious task. But if successful, it can lead to the identification of a novel cis-
regulatory element and the discovery of a whole new regulatory network. The analysis of the 
brinker enhancer revealed the existence of the Silencer Element as a small repressive Dpp 
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response element (Pyrowolakis et al., 2004). Here, we analysed the enhancer of dad, a gene 
activated by Dpp, and report the identification of an analogous Activating Element. 
7.2 Regulation of the Dpp-antagonist Dad 
7.2.1 Function of Dad 
Dad is the only inhibitory Smad found in Drosophila (Tsuneizumi et al., 1997) and a close 
homolog of the vertebrate I-Smads, Smad6 and Smad7. I-Smads are negative regulators of 
TGF-β signalling, due to their ability to interact with the type I receptor and block 
phosphorylation of R-Smads (Hayashi et al., 1997; Imamura et al., 1997; Nakao et al., 1997). 
Initially, Dad was identified as an antagonist of Dpp signalling. Misexpression of dad in the 
wing disc strongly affects growth and leads to the formation of tiny winglets, which can be 
counterbalanced by overexpressing a transgene encoding the constitutively active Dpp 
receptor TkvQD (Tsuneizumi et al., 1997). 
Studies on the molecular functions of inhibitory Smads mainly focused on the vertebrate 
members. It was revealed that I-Smads do not only compete with R-Smads for receptor 
binding, but also cooperate with ubiquitin ligases, so called Smurfs (for Smad ubiquitin 
regulatory factors), to target activated receptor complexes to proteasomal degradation 
(Kavsak et al., 2000). I-Smads are also able to form complexes with R-Smads and lead to 
ubiquitination and degradation of the latter (Murakami et al., 2003). Other functions include 
the recruitment of specific phosphatases to deactivate the type I receptor (Shi et al., 2004). 
While Smad7 acts as a general inhibitor of TGF-β and BMP signalling, Smad6 preferentially 
inhibits the BMP type I receptors ALK-3 and ALK-6. Besides their fundamental role in 
blocking type I receptor signalling, there is also evidence for functions in transcriptional 
regulation. Although I-Smads lack the Smad-specific MH1 DNA-binding domain, they are 
known to be located in the nucleus of most cell types. Smad6 was shown to interact with the 
homeobox transcription factors Hoxc-8 and Hoxc-9 to repress target gene transcription (Bai et 
al., 2000) and to bind DNA, together with Histone deacetylases (Bai and Cao, 2002). 
Interaction with histone deacetylases was also reported for Smad7 (Bai and Cao, 2002). 
Furthermore, Smad6 is able to recruit the transcriptional corepressor CtBP to the promoter of 
the Id1 gene (possibly by interaction with Smad1) and inhibit its transcription (Lin et al., 
2003). 
The function of inhibitory Smads is not restricted to TGF-β signalling. Smad 7 has also been 
associated with the TNF-α and MAPK pathway, where it was reported to inhibit the 
transcriptional activity of NF-κB, induce activation of JNK and activate p38 MAP kinase 
(Edlund et al., 2003; Lallemand et al., 2001; Mazars et al., 2001). A link to the Wnt/Wingless 
pathway was also established when Smad7 was shown to interact with β-catenin and 
LEF1/TCF in a TGF-β dependent manner (Edlund et al., 2005) and induce the degradation of 
β-catenin by direct binding and subsequent recruitment of the E3 ubiquitin ligase Smurf2 
(Han et al., 2006). 
Since inhibitory Smads are crucial for regulating the intensity and duration of TGF-β 
signalling, their dysfunction or misexpression is associated with various diseases classically 
assigned to TGF-β signalling. This includes fibrosis, inflammatory diseases as well as tumor 
progression. Indeed, increased expression levels of Smad7 correlate with a poor prognosis for 
several types of cancers. 
Compared to the enormous body of data gathered about the function, regulation and 
expression of vertebrate inhibitory Smads in physiological and pathological conditions 
(Miyazono, 2007), our knowledge of the Drosophila I-Smad Dad is negligible. Very few 
studies have dealt with the function of Dad. Due to the high structural conservation of fly and 
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vertebrate I-Smads, it is tempting to speculate that Dad acts similarly to Smad6 and Smad7. 
Indeed, it has been shown that Dad binds to the cytosolic domain of the Dpp receptor 
Thickveins and thereby blocks phosphorylation of Mad (Inoue et al., 1998). Recently it has 
been reported that Dad is not able to inhibit signalling of the Activin receptor Baboon in 
heterologous cell culture, but is restricted to the receptors of the BMP pathway, Thickveins 
and Saxophone (Kamiya et al., 2008). Notably, and in contrast to vertebrate I-Smads, Dad 
seems not to recruit dSmurf, the Drosophila homolog of vertebrate Smurfs, since dSmurf 
interacts with Mad but not Dad in a signal-dependent manner (Liang et al., 2003b). 
7.2.2 Genetic control of dad expression 
The transcription of genes encoding vertebrate inhibitory Smads is directly induced by BMP 
signalling (see 4.4.2), and also dad is upregulated in cells receiving Dpp signalling 
(Tsuneizumi et al., 1997). However, until now it has not been shown that this upregulation is 
due to direct Smad binding to the dad enhancer. This is important in light of the discovery 
that another gene, omb, which had been regarded as the prototype of a gene directly activated 
by the Dpp pathway, is actually only derepressed by Dpp signalling via the removal of the 
repressor Brinker and induced by other, hitherto unknown, factors (Sivasankaran et al., 2000). 
Brinker is the default antagonist of the Dpp pathway and represses the majority of Dpp target 
genes in the absence of Dpp signalling (Campbell and Tomlinson, 1999; Jazwinska et al., 
1999a; Jazwinska et al., 1999b; Minami et al., 1999). Consequently, one of the main effects in 
cells responding to Dpp is the downregulation of brinker (Marty et al., 2000). The outcome of 
dpp
pMad brk
ombdad sal
Figure 7.1 
Regulation of Dpp/Brinker target genes in 
the wing imaginal disc. The diffusible 
extracellular ligand Dpp is produced in a 
narrow stripe of cells along the anterior-
posterior border. Its activity gradient can be 
visualized by antibody-detection of phospho-
Mad. The brinker gene, which encodes a 
nuclear repressor, is repressed by the Dpp 
pathway and thus expressed in a 
complementary manner. The sensitivity of gene 
expression to the Dpp gradient can be due to 
activation by the Dpp pathway or repression by 
Brinker. We were able to characterize dad as a 
gene integrating both inputs, similar to sal and 
unlike omb, that is only repressed by Brinker 
and induced by unknown activators. 
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genetic experiments suggests that dad is a Brinker target as well (Marty et al., 2000; Torres-
Vazquez et al., 2001). Our findings reveal that, upon Dpp signalling, dad is not only 
derepressed by removal of Brinker, but also activated by Dpp in a Brinker-independent 
fashion. Thus, dad can be assigned to the member-rich class of genes that are both activated 
by the Dpp pathway and repressed by Brinker (see Fig. 7.1). 
7.2.3 Regulation of a minimal dad enhancer 
Analysing the expression pattern of lacZ reporter transgenes, we were able to identify a 520bp 
enhancer (Dad13) within the second intron of dad that induces an expression pattern very 
similarly to that of the endogenous dad gene. Although we did not perform any rescue 
experiments yet, we consider it to be the minimal enhancer due to this truthful recapitulation. 
Dad13 is inducible by Dpp signalling and sensitive to brinker expression in cell culture 
experiments as well as in vivo. Using purified recombinant DNA-binding domains of Brinker, 
Mad and Medea, we demonstrated the existence of well conserved and largely overlapping 
binding sites for Smads and Brinker. Mad as well as 
Medea compete with Brinker for binding to these 
sites, which implies a similar regulative mechanism 
for the regulation of dad as it has already been 
proposed for a zen and a Ubx enhancer element 
(Kirkpatrick et al., 2001; Rushlow et al., 2001). By 
precise mutations we were able to selectively abolish 
Brinker binding (see Fig. 7.2) and demonstrate that it 
is possible to unlink Smad and Brinker input. 
Importantly, we did not only show the binding of 
rather promiscuously interacting protein domains, but 
also the assembly of a full-length Mad/Medea 
complex on at least three different sites within the Dad13. This kind of complex formation has 
been demonstrated only in the context of the SE before (Pyrowolakis et al., 2004). Several 
genes have been reported to be directly activated by Smads. However, the experimental 
evidence was based on the binding of bacterially produced DNA-binding domains. Therefore, 
our work presents the first example of formation of such a complex in the context of a gene 
activated by Dpp. 
Mutation of two of the sites able to recruit the Mad/Medea complex strongly reduced the 
activity of Dad13 in cell culture assays as well as its capability to drive the expression of a 
lacZ reporter in the embryo. Expression in the wing disc, however, was only mildly affected. 
This might be due to a certain level of redundancy and modularity of the minimal dad 
enhancer and is in accordance with the fact that successive reduction of the size of Dad13 
leads to a constant, but not abrupt, loss of activity. It might also reflect functionally 
overlapping, but still slightly differing mechanisms for regulating dad expression in larval 
imaginal discs and the embryo. 
Brinker   TGGCGYY 
WT        TGGCGCC 
BtM       TGaCGtC 
Mad        GRCGNC 
 
Figure 7.2 
Mutation of a Brk/Mad into an exclusive Mad site.
The consensus binding sequences of Brinker and Mad 
share great similarity, and the major binding sites 
within the dad enhancer (WT) fulfill both. However, 
we demonstrated that it is possible to mutate such a 
site to an exclusive Mad site (BtM), thereby 
abrogating the Brinker input and preserving the Mad 
input.  
D.melanogaster    CCTCAACCTTAA--ATTGTTGATTCTT-CAACTTGTCAAACCGGCTGACAAACCGACCG 
D.pseudoobscura   CCTCAACCTTAAATATTGTTGATTCTT-CAACTTGTCAAACCGGCTGACAAACCAACCG 
D.virilis         --TTCACCTCAA--ATTGTTGATTCTT-CAACTTGTCAAACCGGCTGACAAACCGACTG 
D.mojavensis      --TTCACCTCAG--ATTTTTGATTCTTCCAACTTGTCAAACCGGCTGACAAAACGACCG 
D.yakuba          CCTCAACCTTAA--ATTGTTGATTCTT-CAACTTGTCAAACCGGCTGACAAACCGACCG 
D.erecta          CCTCAACCTTAA--ATTGTTGATTCTT-CAACTTGTCAAACCGGCTGACAAACCGACCG 
consensus         ..*..****.*.  ***.********* ************************.*.**.* 
AP1-like site                                      TGACAAA     TGACAAA     
 
Figure 7.3 
Conservation of the 5’ region of Dad13. The first sixty nucleotides of Dad13 are highly conserved among different Drosophila species,
although they are not absolutely essential for the activity of the enhancer. Remarkable is a duplicated stretch of ten nucleotides (violet) that 
resembles an AP1-like binding site (Tsuji et al., 1998). 
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Due to its ability to control the intensity of Dpp signaling and thus growth and patterning in 
general, dad is a very good candidate for a gene that computes regulatory input from multiple 
factors and signaling pathways, as it has been reported for the enhancers of the vertebrate 
inhibitory I-Smads. Interestingly, Dad13 not only comprises two highly conserved clusters of 
Brinker and Smad sites, separated by a poorly conserved nucleotide stretch, but also a 
perfectly conserved region at the 5’ end that does not include any putative Smad or Brinker 
binding sites. This region contains a duplicated motif of ten nucleotides (Fig 7.3) that 
resembles an AP1-like binding site shown to recruit a Jun/Fos complex (Tsuji et al., 1998). It 
is noteworthy that AP1 has also been reported to bind to the smad7 promoter (Brodin et al., 
2000). However, removal of these sites by designing a construct smaller than Dad13 only 
weakly affected enhancer activity. 
Our results also indicate a role of the TEA-domain transcription factor Scalloped in the 
transcriptional control of dad in the wing imaginal disc. Scalloped has been shown to interact 
with Vestigial (Halder et al., 1998) as well as Yorkie (Goulev et al., 2008; Wu et al., 2008; 
Zhang et al., 2008b) in the regulation of its target genes. Yorkie is a potent activator of cell 
growth and proliferation and is tightly regulated by the Hippo pathway (reviewed by Saucedo 
and Edgar, 2007). Thus, our findings might elucidate a new level of interaction of the Hippo 
and Dpp pathways, two important regulatory networks involved in growth control. Future 
experiments will shed more light on this potential cross-regulation. 
7.2.4 The AE as an integrative activating Dpp response element  
Further dissection of the minimal dad enhancer led to the discovery of a short motif with less 
than twenty nucleotides that was able to recruit a Mad/Medea complex in vitro and drive 
GRCGNCNNNNNGTCTG
Mad
Medea
Schnurri
GRCGNCNNNNNGTCTG
GGCGCCANNNNGNCNN
Mad
Medea
Mad
Medea
Brinker
GGCGCCANNNNGNCNN
AE
SE
with Dpp without Dpp
Figure 7.4 
Architecture of the AE and SE. Although they exert completely contrary effects, the architecture of the AE and SE is very similar. Both are
able to recruit a complex of Mad and Medea upon Dpp signaling. The Smad/SE complex, however, additionally recruits the repressor
Schnurri. This is not the case for the AE that lacks the second T in the blue box. Without Dpp signaling, the repressor Brinker binds to the
AE to inhibit transcription, whereas genes regulated by an SE are activated by other factors. 
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expression of a reporter gene in a dad-like fashion in vivo. Because of its striking similarity to 
the Silencer Element (SE), we termed it Activating Element (AE). The AE very closely 
resembles the SE, which came as a big surprise. We had chosen dad for our studies because 
of its characteristic expression and were totally unbiased when we started the molecular 
dissection of its enhancer. Despite their analogy, the SE and AE differ in several key aspects. 
Due to the arrangement of the Smad binding sites, they are both able to recruit a complex of 
Mad and Medea. But only the SE comprises the second T within the “blue box” (see Fig 7.4), 
which is essential for the recruitment of the repressor Schnurri (Pyrowolakis et al., 2004). 
Furthermore, the AE identified in the dad enhancer is able to interact with the repressor 
Brinker. Brinker competes with Mad for binding to the “red box” of the AE, which fulfills the 
consensus sequence derived from analysis of the SE (GRCGNC) as well as the one of the 
Brinker binding site (TGGCGYY). Thus, the AE and SE are using a very similar sequence to 
exert opposite effects (see Fig 7.5). While genes comprising an SE are consequently repressed 
upon Dpp signaling, the AE allows for Dpp-mediated activation in various developmental 
contexts and at the same time ensures downregulation in the absence of Dpp signalling by 
recruitment of Brinker. 
So far we do not have any evidence that Schnurri, which has been associated also with 
activation (see 4.3.4), acts on the AE. SchnurriCT is not able to bind to the AE. Domains of 
human Schnurri with homology to the N-terminal regions of Schnurri (that are not included in 
SchnurriCT) were shown to bind to the SE (Yao et al., 2006), which might indicate other, so 
Figure 7.5 
Comparison of SE- and AE-mediated transcriptional regulation. The two genes brinker and dad are prototypes of genes whose 
transcription is regulated by an SE and AE, respectively. (A) In the wing imaginal disc, brinker is generally activated by unknown factors, 
but repressed within the Dpp domain by a Mad/Medea/Schnurri complex recruited to the SE. (B) dad expression is complementary, because 
it is induced within the Dpp domain by direct activation via the AE and downregulated outside the Dpp domain by the repressor Brinker (B). 
Expression
Anterior Posterior
Dpp
Anterior Posterior
Expression
Brk BrkDpp
dadbrk
A B
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far unknown, functions of Drosophila Schnurri. However, this is probably not the case in the 
context of the dad enhancer. The observation that expression of dad is lacking in shn mutants, 
can be explained with the derepression of brinker. This becomes evident when looking at 
brk; shn double mutants, where transcription of dad is reconstituted (Marty et al., 2000). 
7.2.5 Flexibility and adaptability of the AE 
The AE consensus sequence GGCGCCA(N)4GNCV is based on the analysis of the AE that 
we found in the dad enhancer. We successfully demonstrated its usefulness for prediction of 
other genes directly activated by the Dpp pathway. In addition, we could also show that 
variants of this sequence as well allow for activation upon Dpp signalling. The length of the 
linker, for example, is not invariant, which is in sharp contrast to the SE. It has been reported 
that Mad and Medea are still able to form a complex on the DNA when the red box and blue 
box within the SE are distantly spaced (Gao and Laughon, 2007). In accordance with this, 
reduction of the linker length by one nucleotide retains activity of the synthetic pentamerized 
construct 5xAE-1. Interestingly, linker extension of one nucleotide is sufficient to convert the 
repressive SE into an activating element. These data indicate that the function of the AE is not 
totally dependent on the linker length, as it is the case for the SE. However, five nucleotides 
might be the optimal spacing for the AE. 
By creating the HASE construct, we were able to show that the activating Smad input can be 
separated from the Brinker input. This raises of course the question: is such an element of 
physiological relevance? Many Dpp target genes are at the same time repressed by Brinker, 
which could be explained with the need to tightly regulate gene transcription and precisely 
define expression boundaries. However, there are genes known such as Race that lack Brinker 
input and rely solely on regulation upon Dpp signalling (Ashe et al., 2000). It is thus 
reasonable to speculate that Drosophila also possesses functional HASEs. The enhancer 
found within the elbow B gene might contain such an endogenous HASE and will be 
subjected to further experiments. 
If there are functional AEs, SEs and HASEs in vivo, what about NASEs? Or with other 
words, are there SEs that at the same time recruit Brinker? The NASE reads out Smad-
mediated repression as well as Brinker repression and leads to constant downregulation. It is 
not easy to imagine situations where such an element would be of use. However, three out of 
nine SEs found in the vicinity of brinker are actually NASEs. It has been shown that Brinker 
represses its own transcription in a negative autoregulatory loop and that this, besides 
regulation via Mad/Medea/Schnurri, is essential for formation of the Brinker gradient (Hasson 
et al., 2001; Moser and Campbell, 2005). The NASEs might represent such sites where 
Brinker and Smad-mediated repression converge. 
Since Smads have been reported to interact with other transcription factors in the induction of 
their target genes, and considering that transcriptional activation is believed to depend on 
local co-activators (Barolo and Posakony, 2002), it came as a surprise that a simple 
pentamerized AE was sufficient to drive expression in such a specific pattern. This brings up 
the question, whether this is due to an intrinsic activation capability of the Smad proteins or 
the recruitment of an unknown co-activator. Interestingly, the expression pattern of 5xHASE 
in the wing imaginal disc pinpoints a regulative role of the selector protein Scalloped. 
Scalloped very likely binds to a motif comprised of the linker and parts of the Mad binding 
site. This potential function for the spacer of the AE might indicate a general concept. The 
spacer is highly variant, often not conserved and differs between different AEs/SEs. Due to its 
flexibility it might offer the possibility to integrate the input of other transcription factors such 
as Scalloped to establish or increase tissue-specificity. 
The AE, SE and derived elements are fascinating examples of how minimal changes in cis-
regulatory sequences provoke dramatic changes in their function. Only few response elements 
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are known that harbor this feature. In the case of the mouse POU domain protein Pit-1, the 
distinction between repression or activation depends on the existence of two base pairs within 
the bipartite binding site (Scully et al., 2000). Also for NFκB binding sites it has been shown 
that a single base pair determines co-factor specificity and whether the expression of the 
respective target gene is induced or restricted (Leung et al., 2004; Luecke and Yamamoto, 
2005). Additionally, it has been demonstrated for the Wingless pathway that mutation of a 
TCF binding site can induce activation instead of repression. However, this requires the 
exchange of an AGAWAW motif by a SCTTTGWW motif, which recruits the same protein, 
but by an uncharacterized, different binding mechanism (Blauwkamp et al., 2008). 
7.2.6 Discovery of a Dpp synregulation group 
We initially attempted to identify an element that is able to read out Dpp signalling 
independent of tissue restrictions, analogous to the SE. The AE gets very close to fulfill these 
criteria. The expression pattern of none of the genes we identified in our genome-wide in 
silico search for AEs (see Fig. 7.6) reflects all domains where Dpp is active. Instead, their 
diversified expression patterns indicate that the AE is able to confer Dpp signalling activity in 
various tissues and at different developmental stages. The expression domains of pannier and 
knirps, for example, are very dissimilar. However, both have been shown (knirps) or are very 
likely (pannier) to be regulated by an AE and depend on Mad/Medea input. Thus, we would 
rather suggest the term synregulation than synexpression, as underlying regulatory 
mechanisms are the same for both genes, but they are not necessarily expressed in 
pannier
knirps
AE19 AE20 (Kni285)
AE21
elbow B
dorsocross
dad
dad
cv-2
doc3
elB
kni
pnr
doc2 doc1
crossveinless-2
AE11AE12
AE10AE7 AE8 AE9
Dad13 DadInt52
2kb
AE5 AE6
Figure 7.6 
Overview of AE containing enhancer. The comparative list shows all enhancer elements analysed in this work (excluding subfragments)
and the corresponding genes. All elements depicted induce expression in domains known to be regulated by Dpp (except AE5, which showed
no activity). AE12 has not been tested yet. Besides Dad13, the importance of the AE for enhancer activity was unequivocally demonstrated
for DadInt52 and AE20. Analysis of the other enhancer elements is ongoing. 
Discussion 
 
 
 
86
overlapping domains. 
The observation that the expression patterns of putative AE containing genes fall into regions 
of Dpp activity, but differ greatly, suggests that the AE acts in concert with other (local) 
activators and repressors to temporally and spatially control transcription. In the case of the 
Kni285 enhancer, this co-activation might depend on Trachealess (Trh), a regulator of 
tracheal cell fates (Isaac and Andrew, 1996; Wilk et al., 1996) that interacts with the basic 
helix-loop-helix (bHLH)-PAS protein dARNT (Ohshiro and Saigo, 1997; Sonnenfeld et al., 
1997; Zelzer et al., 1997). A complex of Trh and dARNT (also known as Tango) has been 
shown to bind to a putative binding site within Kni285 in vitro, and expression of a 444bp 
enhancer construct comprising Kni285 significantly decreased when this site was mutated 
(Reinhard Schuh, personal communication). 
The importance of our findings is substantiated by the fact that most of the enhancer 
fragments predicted to contain a functional AE induce expression in a fashion that implies 
regulation by the Dpp pathway. This was, for example, the case for all constructs derived 
from the Dorsocross locus, the genomic region with the most AE hits. The Dorsocross genes 
have been implied to be directly regulated by Dpp (Hamaguchi et al., 2004; Reim et al., 2003) 
and our study might provide the molecular basis for this assumption. 
However, initial attempts to destroy the central AEs in the Dorsocross enhancer fragments by 
mutating the two central nucleotides of the Mad binding site was not efficient in abrogating 
the activity of the enhancer. This might be due to the insufficiency of the introduced mutation, 
which we are planning to test by more dramatic changes. But the reason is more likely to be 
the redundancy of AEs. The minimal dad enhancer already contains at least three AEs, and 
more careful analysis of the Dorsocross enhancers revealed the existence of several more 
potential AEs. Hence, the redundant and modular nature of the enhancers seems to be a 
common theme for genes that are activated by the Dpp pathway via an AE. This makes 
mutational analysis more difficult. Two exceptions are the 285bp knirps enhancer and the 
second enhancer found in the dad locus, DadInt52. Both include only a single AE, whose 
mutation completely abolishes activity of the enhancer. 
Further experiments will also focus on an enhancer identified in the proximity of pannier. The 
regulatory interactions of dpp and pannier, an important dorsal selector gene in the embryo, 
are not well understood and our findings might help to shed more light on them. 
7.2.7 Phylogenetic conservation of the AE 
Due to the high conservation of the Dpp/BMP pathway and the molecular properties of the 
Smad proteins, it is not unlikely that the function of the AE/SE is phylogenetically conserved. 
The AE impressively shows how the DNA-binding sites of two distinct proteins (Mad and 
Brinker) evolutionarily converged into one motif. No Brinker homolog has been identified in 
vertebrates so far. However, SE-like (and thus AE-like) motifs have been found in the 
enhancers of several vertebrate genes activated by BMP signalling, such as smad7 or the Id 
genes (Karaulanov et al., 2004; Korchynskyi and ten Dijke, 2002). An AE-including BMP 
response element isolated from the Id1 enhancer is even sufficient to drive a reporter gene in a 
pattern partially overlapping with regions of BMP activity in the mouse (Monteiro et al., 
2004). Recently, it has been reported that the function of an SE-like activating element from 
the Xenopus Vent2 promoter is subjected to the same restrictions as the Drosophila SE 
considering the spacer length, and that vertebrate Schnurri is able to form a complex with 
Mad and Medea on this element. These findings imply that vertebrate AE/SE sequences are 
activated by the vertebrate Schnurri homologs. Our experiments with zebrafish embryos do 
not necessarily support this idea, because the pentamerized AE induces lacZ expression 
ventrally in a BMP-dependent manner, also when the linker length is varied. There are several 
explanations possible for this discrepancy. Vertebrate Schnurri proteins might act only on a 
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subset of AE/SE like sequences, or only in a certain developmental context. It is also possible 
that the limitation of the spacer length is specific to the Xenopus Vent2 motif and even caused 
by other reasons. More efforts will have to be made to elucidate the functions of Schnurri, not 
only in vertebrates (where the possible functional redundancy of the three vertebrate Schnurri 
homologs complicates the analysis), but also in Drosophila.  
7.2.8 Open questions 
One of the greatest unanswered questions is certainly which factors bind to the AE besides 
Mad and Medea. Several approaches are conceivable to investigate this issue. We 
demonstrated that it is possible to specifically co-precipitate phosphorylated Mad bound to 
biotinylated AE. It is likely that also other unknown factors can be isolated by this means and 
detected by subjection of the bound complexes to mass spectrometry. 
Alternatively, we are planning a cell culture based RNAi screen. The cell culture assay has 
already been established in this work and is based on the induction of a luciferase gene fused 
to the dad minimal enhancer. This construct is co-transfected with a plasmid encoding the 
constitutively active Dpp receptor TkvQD. A library of double-stranded RNA molecules, 
targeting the majority of the Drosophila genes, is then applied and the effect on the reporter 
gene expression analysed. RNAs directed against genes that are involved in activation of dad 
should lead to a decreased luciferase signal and allow for their identification. 
Probably linked to the prior question, it remains to be elucidated why the 5xAE is able to 
induce diverse and specific expression patterns in the embryo (although absent or only weak 
at early stages), but not in the wing imaginal disc. In this context, it will be insightful to 
illuminate the role of Scalloped. 
The expression of the minimal dad enhancer truthfully recapitulates Dpp signalling activity. 
Classically, activity of the Dpp pathway is visualized using an antibody directed against 
phosphorylated Mad. With the generation of transgenic flies carrying a Dad4::GFP construct, 
we for the first time provide a way to visualize Dpp activity in living tissues. We are 
convinced that this will be of great use to the Drosophila community. 
One question that could be addressed using such a tool is little obvious but of great 
importance. Why is dad ubiquitously and seemingly constantly activated upon Dpp 
signalling? As intensively discussed, the major role of Dad is to antagonize Dpp signalling. 
However, continuous Dpp signalling is required for growth of the wing imaginal disc. And 
inhibition of Dpp signalling leads to loss of dad transcription. What is the consequence of this 
feedback loop? Do cells reacting to Dpp permanently produce Dad and degrade it, together 
with the bound receptor/Smad complex? Or do cells constantly cycle through periods of high 
activity of the Dpp pathway/low levels of Dad and low activity of the Dpp pathway/high 
levels of Dad? 
Addressing these questions will be the aim of future experiments. We believe that the work 
presented here will be of great guidance in successfully answering them. 
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